Methods and compositions for modifying flowering time genes in plants

By introducing mutant alleles at the E1 and E1LB loci of soybean plants, changing the flowering and maturation time, the problem of difficulty in manipulating agronomic traits in different geographical locations is solved, and the adaptability of soybeans in multiple geographical locations is achieved. Increased output.

CN119013410APending Publication Date: 2024-11-22SYNGENTA CROP PROTECITON AG +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380026866.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-11
Filing Date
2023-03-09
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

As an important crop, the flowering time and maturity time of soybeans are greatly affected by the photoperiod conditions, which leads to increased difficulty in manipulating agronomic traits in different geographical locations, especially under different day long conditions, it is difficult to cultivate excellent agronomic traits in multiple geographical locations. soybean variety.

Method used

By introducing new allelic mutations, gene editing technology is used to introduce mutations at the E1 and E1LB loci of soybean plants, changing the flowering and maturation time, allowing plants to advance or delay flowering under different sunshine conditions, thus adapting to multiple geographic areas Location of growth environment.

Benefits of technology

The fine regulation of the flowering and maturity time of soybean plants has been achieved, the scope of adaptation of soybean varieties has been expanded, and the growth and yield in different geographical locations has been improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119013410A_ABST
    Figure CN119013410A_ABST
Patent Text Reader

Abstract

Methods and compositions are provided for modifying the flowering time and / or maturation time of soybean plants to enable the cultivation of these soybean plants in a plurality of geographic locations having different day lengths. Modified soybean plants comprising a non-natural mutant allele at the E1 and / or E1Lb locus are disclosed. These modified plants have shorter flowering and / or maturing times than control plants.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Related application information

[0002] This application claims priority to application PCT / CN2022 / 080339 filed on March 11, 2022, the contents of which are incorporated herein by reference in their entirety.

[0003] Statement Concerning Electronic Submission of Sequence Listings

[0004] A sequence listing in ST.26 format is provided as an alternative to a paper copy, which is submitted pursuant to 37 C.FR §1.821, named 82490.xml, 41 kb in size, generated on March 9, 2023 and submitted via EFS-Web. This sequence listing is hereby incorporated by reference into this specification for its disclosure. Technical Field

[0005] The present disclosure relates to the field of plant biotechnology. In particular, the present invention relates to methods and compositions for modifying the flowering time or maturity time of photoperiodic plants to enable cultivation of these photoperiodic plants in multiple geographic locations with different day lengths. Background Art

[0006] Soybean (Glycine max) is a valuable field crop. Soybean oil extracted from seeds is used in many retail products, such as cooking oil, baked goods, margarine, etc. Soybean is also used as a grain as a food source for both animals and humans. Soybean meal is a component of many foods and animal feeds. The edible protein ingredients produced from soybeans provide a healthier and cheaper alternative to animal protein in meat and dairy products.

[0007] The typical growth cycle of full-season soybeans begins with a long vegetative growth period. Figure 1A As shown, the vegetative stage begins with the emergence of the hypocotyl from the soil (VE), followed by the unfolding of a pair of simple leaflets (VC) at the first node just above the cotyledons. At this stage, the leaflets are fully unfolded so that the leaf edges do not touch. After VC, the plant changes from V1 (where fully developed leaves unfold at the first node) to Vn when the three leaflets unfold at each of the multiple nodes (n).

[0008] When the first open flower is present in any node on the main stem of the plant, the reproductive stage begins (R1 or begins to bloom). The first flower is typically toward the bottom of the plant. When the plant enters full flowering, it enters R2. In this stage, there is an open flower in one of the two uppermost nodes on the main stem, and the flower is fully developed. The reproductive stage includes pod development (R3 and R4), seed development (R5 and R6) and final maturity (R7 and R8). In R3 (beginning to pod stage), there is a pod of at least three-sixteenths of an inch in length in one of the four uppermost nodes with fully developed leaves on the main stem. In R4 (complete pod setting), there is a pod of at least three-quarters of an inch in length in one of the four uppermost nodes with fully developed leaves on the main stem. In R5 (or beginning to seed stage), there is a seed of at least one-eighth of an inch in length in the pod in one of the four uppermost nodes with fully developed leaves on the main stem. In R6 (or the complete seeding stage), there is a pod containing green seeds at one of the four uppermost nodes with fully developed leaves on the main stem, and the green seeds fill the pod cavity. In R7 (or the beginning maturity stage), there is at least one normal pod on the main stem that has reached its mature pod color. In R8 (or the complete maturity stage), at least 95% of the pods have reached their mature pod color. After R8, five to 10 days of dry weather are required to reduce the soybean moisture level to less than 15%.

[0009] Most flowering plants respond to daily photoperiod cycles and are classified as short-day (SD) or long-day (LD) plants based on the photoperiod conditions required to induce flowering. The photoperiod conditions experienced by plants vary with the geographical location (e.g., latitude or longitude) in which they are cultivated. Soybeans are short-day (SD) plants, requiring days shorter than the critical value to induce flowering. Soybean varieties are divided into multiple maturity groups based on their response to photoperiods, such as based on the number of days until flowering occurs. For example, for most North American soybean varieties, the typical planting date is May 1, and the vegetative period of soybean growth can last from 55-65 days, with flowering beginning around mid-July.

[0010] Plant breeders and growers are always looking for new ways to manipulate the cultivation and yield of plants, especially for crops that are important for agronomy. For example, soybean breeders are interested in soybean varieties that can be cultivated in a wide range of geographic locations. Therefore, there is a continuing need in the art for improved compositions and methods for modifying agronomic traits related to flowering time.

[0011] Multiple genes have been identified and discovered that play a role in controlling flowering time and maturity in soybean. The present disclosure provides methods for generating novel and non-natural allelic variations of genes involved in the photoperiodic response of soybean, and using specific allelic combinations to provide soybean plants with a range of modified flowering times. Summary of the invention

[0012] Methods and systems for providing edited plants (e.g., soybean plants) are provided, which have flowering times and / or maturation times that are changed or modified from natural flowering times (e.g., from corresponding control plants that are not edited). In an embodiment, the soybean plant has a flowering time and / or maturation time that is less (e.g., significantly less or slightly less) than the flowering time of the control plant. Compositions of nucleic acid molecules (e.g., expression cassettes or vectors) are also provided, which are capable of introducing targeted editing into the genome of plant cells, particularly into the loci of selected plant genes involved in regulating flowering and / or maturation and / or photoperiod responses, thereby resulting in the production of novel mutant alleles of flowering and / or maturation and / or photoperiod response genes. In an embodiment, the resulting mutant alleles comprise the following sequences, which, when included in the genome of the plant, confer to the plant a modified (e.g., less) flowering time and / or maturation time compared to a plant that does not contain a mutant allele. In an embodiment, a composition produced by a different allele combination of mutant alleles confers to a plant modified (e.g., shorter / fewer) days to flowering, days to maturity, and / or days between flowering and maturity compared to a plant not comprising the allele combination. Such compositions and methods of using such compositions enable the production of plants that can be grown in multiple geographic locations, including locations with shorter or longer days.

[0013] Embodiments of the present invention include nucleic acid molecules, which include nucleotide sequences encoding mutations at the E1 locus and / or E1LB locus of the genome of a soybean plant or plant cell, thereby producing novel alleles at the E1 locus and / or E1LB locus. In an embodiment, mutations are introduced by an expression cassette, which includes a nucleotide sequence encoding mutations at the E1 locus and / or E1LB locus, the E1 locus being operably connected to a promoter, and the E1LB locus being operably connected to a promoter (e.g., the same or different promoters). In an embodiment, mutations are introduced into the E1 locus and / or E1LB locus of the soybean plant genome by genome editing (e.g., using genome modification of a site-directed nuclease). Embodiments of the present invention include plants or plant cells comprising novel alleles at the E1 locus and / or E1LB locus.

[0014] Additional methods of the invention also include the use of mutagenesis and recombination (e.g., directed using chimeric oligonucleotides, meganucleases, zinc fingers, TALENs or CRISPR) to introduce specific strand breaks, recombinant insertions and mutations to engineer in situ changes in the plant genome, and then causing the plant genome mutated in this manner to be altered at the E1 and / or E1Lb loci. Thus, the plant is capable of expressing one or more of the mutant E1 protein and the mutant E1Lb protein, and thus causing the plant to have altered flowering time characteristics. Thus, the invention also includes plants, varieties, and their seeds and progeny with altered flowering time, all of which are derived from the products of the application of the above methods of the invention.

[0015] Embodiments of the present invention include example methods for establishing where a soybean plant or its seeds should grow. In example embodiments, the method includes a) introducing a mutation at the E1 locus and / or E1LB locus of the soybean plant genome (such as via genome modification using a site-directed nuclease); b) selfing the plant for one or more generations to produce a homozygous offspring plant at each of the E1 locus and the E1LB locus; c) obtaining DNA from the offspring plant; d) determining the allele combination of the offspring plant via a first assay of DNA indicating the type of mutation introduced at the E1 locus and a second assay of DNA indicating the type of mutation introduced at the E1LB locus; and e) specifying a change in flowering time of the plant based on the determined allele combination, wherein the change in flowering time is relative to a control plant that does not contain the allele combination. In an embodiment, the editing of the endogenous E1 gene and the E1LB gene includes editing using a DNA modification enzyme (e.g., a site-directed nuclease). In an embodiment, editing includes introducing a mutation at a nuclear localization signal (NLS) at the E1 locus and the E1LB locus of the plant genome. In example embodiments, editing includes introducing mutations at the basic domain of the NLS at the E1 locus and / or the E1LB locus (e.g., at both loci). In example embodiments, editing includes introducing mutations at the second basic domain of the two basic domains of the NLS at the E1 locus and the E1LB locus, wherein the second basic domain is downstream relative to the first basic domain of the NLS. In an embodiment, editing includes transforming a plant cell with an expression cassette comprising (i) a nucleic acid encoding a site-directed nuclease; and (ii) a nucleic acid encoding at least one guide RNA (gRNA) for a target sequence. In an embodiment, the at least one gRNA is directed to a target sequence comprising a nuclear localization signal (NLS) at the E1 locus and the E1LB locus. In example embodiments, the at least one gRNA is directed to a target sequence comprising a second basic domain of a nuclear localization signal (NLS) at the E1 locus and the E1LB locus. In an embodiment, the nucleic acid encoding the site-directed nuclease is operably connected to a first promoter, and the nucleic acid encoding the at least one gRNA is operably connected to a second promoter. In embodiments, the expression cassette further comprises an enhancer operably linked to the first promoter or the second promoter.In an embodiment, the site-directed nuclease is selected from the group consisting of: mega nuclease (MN), zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), Cas9 nuclease, Cfp1 nuclease, dCas9-Fok1, dCpf1-Fok1, chimeric Cas9-cytidine deaminase, chimeric Cas9-adenine deaminase, chimeric FEN1-Fok1, and Mega-TAL, nickase Cas9 (nCas9), chimeric dCas9 non-Fok1 nuclease, and dCpf1 non-Fok1 nuclease. In an embodiment, the editing comprises introducing a mutation into the E1 locus and the E1LB locus, the mutation being selected from the group consisting of: allele substitution, one or more base insertions, one or more base deletions.

[0016] In embodiments, the editing further comprises regenerating a transformed TO plant from the transformed plant cell, the transformed TO plant having a plurality of T1 seeds, wherein the plurality of T1 seeds contain a plurality of unique edits in the E1 locus and the E1LB locus; growing a plurality of T1 plants from the T1 seeds; selfing the T1 plants for one or more generations to obtain offspring plants homozygous at the E1 locus and the E1LB locus. In embodiments, the method further comprises sequencing the E1 locus and the E1LB locus of the offspring plant; sequencing the E1 locus and the E1LB locus of the TO plant; aligning the E1 locus and the E1LB locus sequences of the offspring plant with the corresponding sequences of the offspring plant to determine the type of mutation introduced into the E1 locus and the E1LB locus.

[0017] In embodiments, the allele combination comprises: a loss-of-function El allele or a partially functional El allele; and a loss-of-function ElLB allele or a partially functional ElLB allele. In embodiments, specifying a change in flowering time comprises specifying a relative maturity group value relative to a control plant not comprising the allele combination, wherein optionally, the control plant comprises a wild-type allele at each of the El locus and the ElLB locus. In embodiments, specifying a change in flowering time comprises specifying the number of days that the soybean plant flowers earlier relative to the control plant.

[0018] In other embodiments, a method of producing a soybean plant with a modified flowering time is provided. In an exemplary embodiment, the method includes introducing an edit into the E1 gene of a plant cell to produce a mutant E1 allele having reduced E1 protein function relative to the wild-type E1 allele; introducing another edit into the E1LB gene of the plant cell to produce a mutant E1LB allele having reduced E1LB protein function relative to the wild-type E1LB allele; and regenerating an edited plant from the edited plant cell; and selfing the edited plant to obtain an edited offspring comprising an allele combination containing the mutant E1 allele and the mutant E1LB allele, wherein the edited offspring has a modified flowering time relative to the flowering time of a control plant comprising the wild-type E1 allele and / or the wild-type E1LB allele. In embodiments, the method comprises introducing an edit into the E1 gene, comprising introducing multiple base pair deletions into the E1 gene, wherein the mutant E1 allele encodes a mutant E1 protein comprising an in-frame deletion or a truncated E1 protein; and wherein the edit is introduced into the E1LB gene, comprising introducing multiple base pair deletions into the E1LB gene, wherein the mutant E1LB allele encodes a mutant E1LB protein having an in-frame deletion or a truncated E1LB protein. In embodiments, the truncated E1 protein has no functional activity relative to the wild-type E1 protein, the in-frame deletion mutant E1 protein has partial functional activity relative to the wild-type E1 protein, the truncated E1LB protein has no functional activity relative to the wild-type E1LB protein, and the in-frame deletion mutant E1LB protein has partial functional activity relative to the wild-type E1LB protein.

[0019] Embodiments of the invention further include gene-edited plants and edited progeny plants comprising any of the listed allele combinations. In embodiments, the flowering time of the edited progeny plant is modified (e.g., longer or shorter) compared to the flowering time of the control plant. In embodiments, the relative maturity group value of the edited progeny plant is different from the relative maturity group value of the control plant.

[0020] Brief description of the sequences in the sequence listing

[0021] SEQ ID NO: 1 is the coding sequence (CDS) of the wild-type E1 gene from soybean (G. max).

[0022] SEQ ID NO:2 is the amino acid (AA) sequence of the wild-type E1 protein encoded by SEQ ID NO:1.

[0023] SEQ ID NO: 3 is the coding sequence (CDS) of the wild-type E1Lb gene from soybean.

[0024] SEQ ID NO:4 is the amino acid (AA) sequence of the wild-type E1Lb protein encoded by SEQ ID NO:3.

[0025] SEQ ID NO: 5 is the nucleotide sequence of a mutant E1 allele having an 8 bp deletion at positions 147 to 154 of SEQ ID NO: 1. The deletion results in a loss of function of the E1 allele.

[0026] SEQ ID NO: 6 is the amino acid (AA) sequence of the prematurely truncated E1 protein encoded by SEQ ID NO: 5. The truncated protein of SEQ ID NO: 6 does not exhibit any E1 activity.

[0027] SEQ ID NO:7 is the nucleotide sequence of a mutant E1 allele having a 13 bp deletion at positions 144 to 156 of SEQ ID NO:1. The deletion results in a loss of function of the E1 allele. SEQ ID NO:8 is the amino acid (AA) sequence of the prematurely truncated E1 protein encoded by SEQ ID NO:7. The truncated protein of SEQ ID NO:8 does not exhibit any E1 activity.

[0028] SEQ ID NO: 9 is the nucleotide sequence of a mutant E1 allele having a 25 bp deletion at positions 131 to 155 of SEQ ID NO: 1. The deletion results in a loss of function of the E1 allele.

[0029] SEQ ID NO: 10 is the amino acid (AA) sequence of the prematurely truncated E1 protein encoded by SEQ ID NO: 9. The truncated protein of SEQ ID NO: 10 does not exhibit any E1 activity.

[0030] SEQ ID NO: 11 is the nucleotide sequence of a mutant E1 allele having a 9 bp in-frame deletion at positions 146 to 154 of SEQ ID NO: 1. The deletion renders the E1 allele partially functional.

[0031] SEQ ID NO: 12 is the amino acid (AA) sequence of a mutant E1 protein having an in-frame deletion encoded by SEQ ID NO: 11. The in-frame deletion mutant E1 protein of SEQ ID NO: 12 exhibits reduced E1 activity.

[0032] SEQ ID NO: 13 is the nucleotide sequence of a mutant E1 allele having a 15 bp substitution at positions 145 to 159 of SEQ ID NO: 1. The resulting in-frame deletion renders the E1 allele partially functional.

[0033] SEQ ID NO: 14 is the amino acid (AA) sequence of the prematurely truncated E1 protein encoded by SEQ ID NO: 13. The in-frame deletion mutant E1 protein of SEQ ID NO: 14 does exhibit reduced E1 activity.

[0034] SEQ ID NO: 15 is the nucleotide sequence of a mutant E1Lb allele having a 7 bp deletion at positions 149 to 155 of SEQ ID NO: 3. The deletion results in a loss of function of the E1Lb allele.

[0035] SEQ ID NO: 16 is the amino acid (AA) sequence of the prematurely truncated E1Lb protein encoded by SEQ ID NO: 15. The truncated protein of SEQ ID NO: 16 does not exhibit any E1Lb activity.

[0036] SEQ ID NO: 17 is the nucleotide sequence of a mutant E1Lb allele having a 139 bp deletion at positions 13 to 151 of SEQ ID NO: 3. The deletion results in a loss of function of the E1Lb allele.

[0037] SEQ ID NO: 18 is the amino acid (AA) sequence of the prematurely truncated E1Lb protein encoded by SEQ ID NO: 17. The truncated protein of SEQ ID NO: 18 does not exhibit any E1Lb activity.

[0038] SEQ ID NO: 19 is the nucleotide sequence of a mutant E1Lb allele having a 3 bp in-frame deletion at positions 149 to 151 of SEQ ID NO: 3. The deletion renders the E1Lb allele partially functional.

[0039] SEQ ID NO: 20 is the amino acid (AA) sequence of a truncated E1Lb protein with an in-frame deletion encoded by SEQ ID NO: 19. The in-frame deletion mutant protein of SEQ ID NO: 20 exhibits reduced E1Lb activity.

[0040] SEQ ID NO: 21 is the nucleotide sequence of a mutant E1Lb allele having a 6 bp in-frame deletion at positions 149 to 154 of SEQ ID NO: 3. The deletion renders the E1Lb allele partially functional.

[0041] SEQ ID NO: 22 is the amino acid (AA) sequence of a mutant E1Lb protein having an in-frame deletion encoded by SEQ ID NO: 21. The in-frame deletion mutant protein of SEQ ID NO: 22 exhibits reduced E1Lb activity.

[0042] SEQ ID NO: 23 is the nucleotide sequence of a mutant E1Lb allele having a 9 bp in-frame deletion at positions 148 to 156 of SEQ ID NO: 3. The deletion renders the E1Lb allele partially functional.

[0043] SEQ ID NO: 24 is the amino acid (AA) sequence of a mutant E1Lb protein having an in-frame deletion encoded by SEQ ID NO: 22. The in-frame deletion mutant protein of SEQ ID NO: 22 exhibits reduced E1Lb activity.

[0044] SEQ ID NOs: 25-26 are the nucleotide sequences of a set of primers (forward and reverse primers, respectively) used to amplify the E1Lb allele during PCR.

[0045] SEQ ID NOs: 27-28 are the nucleotide sequences of a set of primers (forward and reverse primers, respectively) used to amplify the E1 allele during PCR.

[0046] SEQ ID NO: 29 is the nucleotide sequence of a primer used for sequencing the E1Lb allele.

[0047] SEQ ID NO: 30 is the nucleotide sequence of a primer used for sequencing the E1 allele.

[0048] SEQ ID NO: 31-32 is the nucleotide sequence of a set of primers (forward and reverse primers, respectively) used to amplify the LbCas12a gene during PCR.

[0049] SEQ ID NOs: 33-34 are the nucleotide sequences of a set of primers (forward and reverse primers, respectively) used to amplify the Adh gene during PCR.

[0050] SEQ ID NO: 35 is the nucleotide sequence of a probe for detecting LbCas12a.

[0051] SEQ ID NO: 36 is the nucleotide sequence of a probe for detecting Adh.

[0052] SEQ ID NO: 37 is the nucleotide sequence of a synthetic guide RNA (gRNA) for targeting the second basic domain of the nuclear localization signal (NLS) of both wild-type E1 and E1Lb proteins, thereby generating mutant E1 and E1Lb alleles. BRIEF DESCRIPTION OF THE DRAWINGS

[0053] This application includes the following figures. These figures are intended to illustrate certain embodiments and / or features of the compositions and methods and to supplement any one or more descriptions of the compositions and methods. These figures do not limit the scope of the compositions and methods unless the written description explicitly indicates that this is the case.

[0054] Figure 1A Different developmental stages of a soybean plant are shown.

[0055] Figure 1B Depicted is the change in color of the pods as they mature.

[0056] Figure 2 is a schematic diagram of vector 25462, which is used for Agrobacterium-mediated transformation of mature soybean seeds to generate targeted mutations in the GmE1 and GmE1Lb genes.

[0057] Figure 3A The carrier 25462 ( Figure 2 )'s gRNA (SEQ ID NO: 37) targets the second basic domain of the NLS of both the E1 and E1Lb genes.

[0058] Figure 3B An alignment of the second basic domain of the NLS of both the E1 and E1Lb genes is shown to determine the consensus sequence for generating gene editing gRNA target sequences.

[0059] Figure 4A-4B The alignment of the homozygous mutant sequence at the E1 locus with the wild-type allele is shown to determine the variation at the target sequence. The alignment at the nucleotide sequence level is shown in Figure 4A The amino acid sequence level alignment is shown in Figure 4B middle.

[0060] Figure 5A-Figure 5B The alignment of the homozygous mutant sequence at the E1Lb locus with the wild-type allele is shown to determine the variation at the target sequence. The alignment at the nucleotide sequence level is shown in Figure 5A The amino acid sequence level alignment is shown in Figure 5B middle.

[0061] Figure 6Shown is an alignment of the sequence of an in-frame deletion mutation at the second basic NLS domain of the target sequence relative to the wild-type allele, and the resulting in-frame deletion allele. The alignment is shown at the nucleotide sequence level and the amino acid sequence level.

[0062] Figure 7 Shown is an alignment of the sequence of a loss-of-function deletion mutation at the second basic NLS domain of the target sequence relative to the wild-type allele, and the resulting loss-of-function deletion allele. The alignment is shown at the nucleotide sequence level and the amino acid sequence level.

[0063] Figure 8 The phenotype of soybean plants of the E1 generation containing the novel allele combination is shown.

[0064] Figure 9-11 The phenotype of E2 generation soybean plants containing the novel allele combination is shown.

[0065] Fig.12 The phenotype of E2 generation soybean plants containing the novel allele combination is shown.

[0066] Fig.13 Shown are the phenotypes of soybean plants of the E3 generation containing the novel allele combination.

[0067] definition

[0068] Unless otherwise defined below, all technical and scientific terms used herein are intended to have the same meaning as commonly understood by those of ordinary skill in the art. Reference to the technology employed herein is intended to refer to the technology commonly understood in the art, including variations of those technologies and / or alternatives to equivalent technologies that are well known to those of ordinary skill in the art. Although it is believed that the following terms can be well understood by those of ordinary skill in the art, the following definitions are stated to facilitate explanation of the subject matter disclosed in this application.

[0069] In accordance with long-standing patent law conventions, the terms "a / an" and "the" as used in this application (including the claims) mean "one or more". For example, the phrase "a / a cell" refers to one or more cells, and in some embodiments may refer to tissues and / or organs. Similarly, the phrase "at least one / a kind", when used herein to refer to an entity, refers to, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 75, 100 or more of the entity, including but not limited to all integer values ​​between 1 and 100 and integers greater than 100.

[0070] Unless otherwise indicated, all numbers expressing amounts of ingredients, reaction conditions, and the like used in the specification and claims are to be understood as modified in all instances by the term "about". As used herein, the term "about", when referring to a measurable value such as an amount of mass, weight, time, volume, concentration, or percentage, is meant to encompass variations of ±20% from the specified amount in some embodiments, ±10% from the specified amount in some embodiments, ±5% from the specified amount in some embodiments, ±1% from the specified amount in some embodiments, ±0.5% from the specified amount in some embodiments, and ±0.1% from the specified amount in some embodiments, as such variations are suitable for performing the disclosed methods and / or using the disclosed compositions, nucleic acids, polypeptides, and the like. Therefore, unless indicated to the contrary, the numerical parameters set forth in the specification and the appended claims are approximations that may vary depending upon the desired properties sought to be obtained by the subject matter disclosed herein.

[0071] As used herein, the term "allele" refers to a variant or alternative nucleotide sequence at a gene or a specific genetic locus. If, relative to a wild-type allele, there are one or more mutations or edits in the nucleotide sequence of a mutant allele, such an allele can be considered to be (i) wild-type or (ii) mutant. In a diploid, a single allele at each locus is inherited by an offspring individual from each parent, respectively. Although one of ordinary skill in the art understands that the allele in any particular individual does not necessarily represent all alleles present in the species, the two alleles present in a given locus in a diploid organism occupy a corresponding position on a pair of homologous chromosomes.

[0072] With respect to wild-type allele, the mutant allele of gene can have gene activity or expression level that reduces or eliminates.For diploid organisms (such as corn and soybean), the first allele can appear on a chromosome, and the second allele can appear at the same locus on the second homologous chromosome.If an allele at the locus on a chromosome of plant is a mutant allele, and another corresponding allele on the homologous chromosome of plant is wild-type, then plant is described as heterozygous to mutant allele.But if two alleles at the locus are mutant alleles, then plant is described as homozygous to mutant allele.To the mutant allele at the locus, be homozygous plant can comprise identical mutant allele or different mutant allele (if heteroallele or double allele).

[0073] "Allelic variation" refers to the variation phenomenon of the allele sequence form at a given genetic locus. Allelic variation results in the production of two or more allelic variants. Variants can be naturally occurring and reflect genetic differences between individuals of the same species. Such natural variations may occur due to natural breeding patterns. Alternatively, variants can be non-naturally occurring and are artificially created (e.g., by breeders or scientists), such as using mutagenesis and / or gene editing techniques. In an embodiment of the present invention, the allelic variants of the soybean E1 gene and / or E1LB gene are produced by a gene editing method that results in the introduction of mutations. In an additional or alternative embodiment of the present invention, the allelic variants of the soybean E1 gene and / or E1LB gene can be produced by chemical mutagenesis, transposon insertion or excision or any other known mutagenesis techniques.

[0074] In an exemplary embodiment, the mutation introduced into the E1 and / or E1LB locus is an allele replacement, one or more base pair insertions, or one or more base pair deletions. The base pair insertions or base pair deletions may include 3n base mutations, wherein a multiple of 3 base pairs is deleted or inserted (e.g., an insertion or deletion of 3bp, 6bp, 9bp, 12bp, 15bp, 18bp, etc.), thereby not affecting the reading frame of the gene. Alternatively, the base pair insertion or deletion may not be a multiple of 3 base pairs (e.g., an insertion or deletion of 2bp, 4bp, 5bp, 7bp, 11bp, etc.), thereby affecting the reading frame of the gene.

[0075] In a specific embodiment, the mutation is a truncated mutation, wherein the mutation can result in the introduction of a stop codon into a gene at an earlier position than expected. Transcription of the resulting mutant allele terminates at an earlier position than the expected stop codon, thereby producing a truncated protein that is shorter than the corresponding wild-type protein.

[0076] In other specific embodiments, the mutation is an in-frame deletion mutation, in which an integer multiple of three base pairs (i.e., 3n base pairs) is deleted. Since three base pairs encode a single amino acid, the result of the in-frame deletion is to maintain the reading frame of the transcript (i.e., no frameshift mutation is introduced), however, the transcript produced by the mutant allele encodes a mutant protein shorter than the corresponding wild-type protein. Both in-frame deletions and truncation mutations in a gene lead to a mutated allele, which encodes a shortened protein, which has a reduced function (e.g., partial loss of function or complete loss of function) compared to the protein encoded by the wild-type (i.e., unmutated) allele.

[0077] As used herein, "allele combination" refers to a specific combination of alleles present at more than one unique position or locus. Embodiments of the present invention include multiple allele combinations at the E1 and E1LB loci. Non-limiting examples of allele combinations at the E1 and E1LB loci include:

[0078] (i) a first allele combination comprising a mutant E1LB allele resulting in partial expression of the E1LB protein and a wild-type E1 allele;

[0079] (ii) a second allele combination comprising a mutant E1LB allele resulting in loss of E1LB protein expression and a wild-type E1 allele;

[0080] (iii) a third allele combination comprising a mutant E1LB allele that results in partial expression of the E1LB protein and a mutant E1 allele that results in partial expression of the E1 protein;

[0081] (iv) a fourth allele combination comprising a mutant E1LB allele resulting in loss of expression of the E1LB protein and a mutant E1 allele resulting in partial expression of the E1 protein;

[0082] (v) a fifth allele combination comprising a mutant E1LB allele resulting in partial expression of the E1LB protein and a mutant E1 allele resulting in loss of expression of the E1 protein;

[0083] (vi) a sixth allele combination, which comprises a mutant E1LB allele that causes a loss of expression of the E1LB protein and a mutant E1 allele that causes a loss of expression of the E1 protein;

[0084] (vii) a seventh allelic combination comprising a wild-type E1LB allele and a mutant E1 allele resulting in partial expression of the E1 protein;

[0085] (viii) an eighth allele combination comprising a wild-type E1LB allele and a mutant E1 allele resulting in loss of E1 protein expression; and

[0086] (ix) A ninth allelic combination comprising wild-type alleles at both the E1 and E1LB loci.

[0087] In embodiments, the flowering time of a non-naturally occurring soybean plant comprising any one of the first to eighth non-naturally occurring allele combinations disclosed above is modified relative to a control plant comprising a ninth allele combination of a wild-type E1 allele and a wild-type E1LB allele. In specific embodiments, the modified flowering time of a non-naturally occurring soybean plant comprising any one of the first to eighth non-naturally occurring allele combinations is less than (e.g., slightly less than or significantly less than) the flowering time of a ninth allele combination of a wild-type E1 allele and a wild-type E1LB allele.

[0088] Based on the resulting phenotype, the mutant allele at the locus can be dominant or recessive. In an embodiment, a first allele combination comprising a mutant E1LB allele that results in partial expression of the E1LB protein and a wild-type E1 allele is homozygous recessive at the E1LB locus and homozygous dominant at the E1 locus; a second allele combination comprising a mutant E1LB allele that results in loss of expression of the E1LB protein and a wild-type E1 allele is homozygous recessive at the E1LB locus and homozygous dominant at the E1 locus; a mutant E1LB allele that results in partial expression of the E1LB protein and a wild-type E1 allele is homozygous recessive at the E1LB locus and homozygous dominant at the E1 locus; and a mutant E1L allele that results in partial expression of the E1LB protein and a wild-type E1 allele is homozygous recessive at the E1LB locus and homozygous dominant at the E1 locus. The third allele combination of the B allele and the mutant E1 allele that causes partial expression of the E1 protein is homozygous recessive at the E1LB locus and homozygous recessive at the E1 locus; the fourth allele combination comprising the mutant E1LB allele that causes loss of expression of the E1LB protein and the mutant E1 allele that causes partial expression of the E1 protein is homozygous recessive at the E1LB locus and homozygous recessive at the E1 locus; the fourth allele combination comprising the mutant E1LB allele that causes partial expression of the E1LB protein is homozygous recessive at the E1LB locus and homozygous recessive at the E1 locus. The fifth allele combination comprising the mutant E1 allele causing loss of expression of the E1 protein and the mutant E1 allele causing loss of expression of the E1 protein is homozygous recessive at the E1LB locus and is homozygous recessive at the E1 locus; the sixth allele combination comprising the mutant E1LB allele causing loss of expression of the E1LB protein and the mutant E1 allele causing loss of expression of the E1 protein is homozygous recessive at the E1LB locus and is homozygous recessive at the E1 locus; the sixth allele combination comprising the wild-type E1LB allele and the mutant E1 allele causing partial expression of the E1 protein is homozygous recessive at the E1LB locus and is homozygous recessive at the E1 locus. The seventh allele combination of the wild-type E1LB allele is homozygous dominant at the E1LB locus and homozygous recessive at the E1 locus; the eighth allele combination comprising the wild-type E1LB allele and the mutant E1 allele that causes loss of E1 protein expression is homozygous dominant at the E1LB locus and homozygous recessive at the E1 locus; and the ninth allele combination comprising the wild-type allele at both the E1 and E1LB loci is homozygous dominant at the E1LB locus and homozygous dominant at the E1 locus.

[0089] In an embodiment of the present invention, the allele combination of a plant at the E1 and E1LB loci can be determined via molecular marker-based assays, such as a first assay of plant DNA indicating the type of mutation introduced at the E1 locus and a second assay of DNA indicating the type of mutation introduced at the E1LB locus.

[0090] In an embodiment, the allele combination indicates a change in flowering time of a plant relative to a control plant not comprising the allele combination (e.g., a control plant of the ninth allele combination comprising one or more wild-type alleles or comprising wild-type alleles at both loci).

[0091] As used herein, the term "and / or," when used in the context of listing entities, refers to the entities either alone or in combination. Thus, for example, the phrase "A, B, C, and / or D" includes A, B, C, and D individually, but also includes any and all combinations and subcombinations of A, B, C, and D (e.g., AB, AC, AD, BC, BD, CD, ABC, ABD, and BCD). In some embodiments, the one or more elements referred to by "and / or" may also be present alone in single or multiple occurrences in one or more combinations and / or one or more subcombinations.

[0092] As used herein, phrase "associated with ... " refers to the identifiable and / or measurable relationship between two entities.For example, phrase "associated with soybean maturity " refers to proterties, locus, gene, allele, marker, phenotype etc. or its expression, and their presence or absence can affect the number of days that soybean plant is in the vegetative state used.Therefore, when marker is linked to proterties and when the presence of marker indicates whether desired proterties or proterties form will and / or will occur in the plant / germplasm comprising marker to what extent, then this marker is "associated" with this proterties.Similarly, when marker is linked to allele and when the presence of marker indicates whether allele is present in the plant / germplasm comprising marker, this marker is "associated" with this allele.For example, "marker associated with the allele of soybean maturity gene E1 " refers to such marker, and its presence or absence can be used to predict whether E1 allele exists and is responsible for the flowering time of plant.

[0093] A "dominant maturity allele" is an allele that affects the maturity of a plant when present in a single copy (heterozygous) or in two copies (homozygous). A "recessive maturity allele" is an allele that affects the maturity of a plant only when present in two copies (homozygous), but does not affect the maturity of a plant when present in a single copy (heterozygous).

[0094] The term "comprising" is synonymous with "including," "containing," and "characterized by," is inclusive or open-ended, and does not exclude additional, unrecited elements and / or method steps. "Comprising" is a term that means the specified elements and / or steps are present, but other elements and / or steps may be added and still fall within the scope of the relevant subject matter.

[0095] As used herein, the phrase "consisting of" excludes any elements, steps or ingredients not specifically recited. When the phrase "consisting of" appears in a clause of the body of a claim, rather than directly following the preamble, it limits only the elements set forth in the clause; other elements are not excluded from the claim as a whole.

[0096] As used herein, the phrase "consisting essentially of limits the scope of the associated disclosure or claim to the specified materials and / or steps, plus those that do not materially affect one or more basic and novel characteristics of the disclosed and / or claimed subject matter.

[0097] With respect to the terms "comprising," "consisting essentially of," and "consisting of," where one of these three terms is used herein, the subject matter disclosed and claimed in the present application may, in some embodiments, include the use of either of the other two terms. For example, if the subject matter, in some embodiments, relates to a soybean plant comprising a genomic interval containing a mutant E1LB allele in the genome of the soybean plant, it should be understood that the disclosed subject matter therefore also encompasses a soybean plant having a genomic interval consisting essentially of, in some embodiments, the mutant E1LB allele and a soybean plant having a genomic interval consisting of, in some embodiments, the mutant E1LB allele. Similarly, it should also be understood that in some embodiments, the methods for the disclosed subject matter include the steps disclosed herein, in some embodiments, the methods for the subject matter disclosed in the present application consist essentially of the disclosed steps, and in some embodiments, the methods for the subject matter disclosed in the present application consist of the steps disclosed herein.

[0098] As used herein, a "cultivar" is a plant species or variety that has been intentionally created or selected and maintained by breeding.

[0099] As used herein, "determinate growth habit" means that vegetative growth ceases after the main stem terminates in a cluster of flowers. In contrast, "indeterminate growth habit" means that leaves and flowers develop simultaneously throughout a portion of its reproductive life, with one to three pods at the terminal apex.

[0100] As used herein, "E1 gene" or its allele is referenced to GmE1 or Glyma.06G207800 (www(.)soybase(.)org) and is associated with flowering time and maturity, and is located in the pericentromeric region of chromosome 6. The E1 gene (SEQ ID NO: 1) is intronless and encodes an E1 protein (SEQ ID NO: 2) that contains a putative two-component nuclear localization signal (NLS) and a domain (B3-like domain) distantly related to the plant-specific B3 domain (Xia, ZJ et al. Proc Natl Acad Sci USA. [Proceedings of the National Academy of Sciences of the United States] 109, E2155-E2164 (2012)). E1 is a transcription factor. E1 is considered a contributor to flowering time variation in soybean cultivars. In addition to its effects on post-flowering responses, E1 also has an effect on pre-flowering development. E1 is expressed in a dual mode, with expression under long day (LD) conditions being higher than expression under short day (SD) conditions. E1 is a putative transcription factor (TF) that negatively controls GmFT2a and GmFT5a to delay flowering in a background with functional PHYA genes (E3, E4) and LD conditions.

[0101] Natural or intentionally introduced mutations in the E1 gene result in altered E1 activity and modified flowering time in soybean plants comprising the mutant gene. In embodiments of the invention, mutations in the E1 gene result in non-natural E1 alleles having reduced activity compared to the corresponding wild-type allele. Modified plants comprising non-natural E1 alleles have modified flowering time and / or maturity time compared to plants comprising wild-type E1 alleles. In specific embodiments, modified plants comprising non-natural E1 alleles have less or shorter flowering time than plants comprising wild-type E1 alleles.

[0102] As used herein, "E1LB gene" or its alleles are referenced to the soybean gene GmE1Lb or Glyma.04G143300.1 (www(.)soybase(.)org) on ​​chromosome 4 of the soybean genome, which can control the onset of flowering (Xu, M. et al. Plant Physiol. 168, 1735-1746 (2015)). The function of this gene in flowering is similar to that of E1. It was found that virus-induced silencing of E1Lb upregulated the expression of FT2a and FT5a and led to early flowering. E1Lb delays flowering under long-day conditions by inhibiting the expression of FT2a and FT5a independently of E1.

[0103] Natural or intentionally introduced mutations in the E1Lb gene result in altered E1Lb activity and modified flowering time in soybean plants comprising the mutant gene. In embodiments of the invention, mutations in the E1Lb gene result in a non-natural E1 allele having reduced activity compared to the corresponding wild-type allele. The modified plants comprising the non-natural E1Lb allele have modified flowering time and / or maturity time compared to plants comprising the wild-type E1Lb allele. In specific embodiments, the modified plants comprising the non-natural E1Lb allele have less or shorter flowering time than plants comprising the wild-type E1Lb allele.

[0104] As used herein, the term "gene" refers to a unit of inheritance comprising a DNA sequence that occupies a specific location on a chromosome and contains the genetic instructions for a specific characteristic or trait in an organism.

[0105] A "genetic map" is a description of the genetic linkage relationships between loci on one or more chromosomes within a given species, usually depicted in a graphical or tabular form. A genetic map is different from a physical map in that a genetic map is a description of the location of genetic elements (e.g., genes, alleles, chromosomal loci, markers, etc.) on sequenced chromosomes.

[0106] As used herein, the term "human-induced mutation" refers to any mutation that occurs due to direct or indirect human action. This term includes, but is not limited to, mutations obtained by any targeted mutagenesis and gene editing methods.

[0107] As used herein, "introduction" refers to delivery, expression, application, transportation, transfer, penetration or other similar terms to indicate the delivery of a desired nucleic acid or protein or a combination thereof to an object. For example, a nucleic acid encoding a site-directed nuclease and optionally at least one guide RNA can be introduced into a plant embryo. Similarly, existing editing machinery (comprising a site-directed nuclease protein and optionally at least one guide RNA) can be introduced into sterile soybean seeds by administering appropriate cell-penetrating chemicals and / or cell-penetrating peptides.

[0108] As used herein, "line" refers to a group of individual plants from similar parents with similar traits. "Improved line" is any line produced from breeding and selection for advantageous agronomic performance. In addition, improved lines are sufficiently homogeneous and homozygous to be used in commercial production. Improved lines can be used for further breeding work to develop new improved lines. Improved plants are any plants from improved lines.

[0109] As used herein, "locus" is a chromosomal locus or region where a polymorphic nucleic acid, trait determinant, gene or marker is located."Locus" can be shared by two homologous chromosomes to refer to their corresponding loci or regions.

[0110] As used herein, the terms "marker probe" and "probe" refer to nucleotide sequences or nucleic acid molecules that can be used to detect the presence or absence of a sequence within a larger sequence, for example, a nucleic acid probe that is complementary to all or part of a marker or marker locus by nucleic acid hybridization. Marker probes comprising about 8, 10, 15, 20, 30, 40, 50, 60, 70, 80, 90, 100 or more consecutive nucleotides can be used for nucleic acid hybridization.

[0111] As used herein, when identifying the presence / absence of a gene or allele (such as an allele at a soybean maturity-related locus (such as at an E1 and / or E1LB locus)), the term "molecular marker" can be used to refer to a genetic marker as defined above or its encoded product (e.g., a protein) used as a reference point. Molecular markers can be derived from a genomic nucleotide sequence or an expressed nucleotide sequence (e.g., from RNA, cDNA, etc.). The term also refers to a nucleotide sequence that is complementary to a marker sequence or to a nucleotide sequence that is located on its flank, such as a nucleotide sequence that is used as a probe and / or primer that can amplify a marker sequence. When nucleotide sequences specifically hybridize in a solution, these nucleotide sequences are "complementary" (e.g., according to the Watson-Crick base pairing rule). This term also refers to a genetic marker that indicates a trait by the absence of a nucleotide sequence that is complementary to a marker sequence or to a nucleotide sequence that is located on its flank (such as a nucleotide sequence that is used as a probe and / or primer that can amplify a marker sequence).

[0112] As used herein, the terms "nucleotide sequence", "polynucleotide", "nucleic acid sequence", "nucleic acid molecule" and "nucleic acid fragment" refer to single-stranded or double-stranded polymers of RNA or DNA, optionally containing synthetic, non-natural, and / or altered nucleotide bases. "Nucleotide" is a monomeric unit from which DNA or RNA polymers are constructed and consists of a purine or pyrimidine base, a pentose sugar and a phosphate group. Nucleotides (usually found in their 5'-monophosphate form) are represented by their single-letter names as follows: "A" represents adenylic acid or deoxyadenylic acid (for RNA or DNA, respectively), "C" represents cytidylic acid or deoxycytidylic acid, "G" represents guanylic acid or deoxyguanylic acid, "U" represents uridylic acid, "T" represents deoxythymidylic acid, "R" represents purine (A or G), "Y" represents pyrimidine (C or T), "K" represents G or T, "H" represents A or C or T, "I" represents inosine, and "N" represents any nucleotide.

[0113] As used herein, "modified" in the context of a plant, plant seed, plant part, plant cell and / or plant genome refers to a plant, plant seed, plant part, plant cell and / or plant genome that comprises engineered changes in the expression level and / or coding sequence of one or more of the E1 gene and the E1LB gene relative to a wild-type or control plant, plant seed, plant part, plant cell and / or plant genome (such as affecting (e.g., reducing or eliminating) the expression level or activity of one or more endogenous E1 and / or E1LB genes via a genome editing event or mutation). The term "modified" may further refer to a plant, plant seed, plant part, plant cell and / or plant genome having one or more mutations that affect the expression of one or more endogenous E1 and / or E1LB genes, the one or more mutations being introduced by chemical mutagenesis, transposon insertion or excision or any other known mutagenesis technique or introduced by genome editing. Therefore, for the sake of clarity, modified plants, plant seeds, plant parts, plant cells and / or plant genomes include mutant and / or edited plants, plant seeds, plant parts, plant cells and / or plant genomes that have modified expression levels, expression patterns and / or coding sequences of one or more of the E1 and E1LB genes relative to wild-type or control plants, plant seeds, plant parts, plant cells and / or plant genomes. The modified plants can be homozygous or heterozygous for any given mutation or edit, and / or can be biallelic at the E1 and / or E1LB loci. If each copy of the gene is modified by a different allele (i.e., different one or more mutations and / or one or more edits), the modified plant is biallelic to the E1 and / or E1LB genes, wherein each allele reduces the expression level and / or activity of the gene. The modified plant or seed can contain a variety of molecular changes that affect the expression of one or more E1 and / or E1LB genes, including genetic and / or epigenetic modifications. Modified plants, plant parts, seeds, etc. may have been subjected to mutagenesis, genome editing or site-specific integration (e.g., without limitation, via methods using site-specific nucleases), genetic transformation (e.g., without limitation, via methods of Agrobacterium transformation or microprojectile bombardment), or a combination thereof. Such "modified" plants, plant seeds, plant parts, and plant cells include plants, plant seeds, plant parts, and plant cells that are progeny of "modified" plants, plant seeds, plant parts, and plant cells or that are derived from "modified" plants, plant seeds, plant parts, and plant cells, which retain molecular changes (e.g., changes in expression levels and / or activity) of the E1 and / or E1LB genes. The modified seeds provided herein can produce the modified plants provided herein. The modified plants, plant seeds, plant parts, plant cells, or plant genomes provided herein can comprise a recombinant DNA construct or vector or genome editing as provided herein.A "modified plant product" can be any product made from a modified plant, plant part, plant cell, or plant chromosome as provided herein, or any part or component thereof.

[0114] As used herein, the term "nucleotide sequence identity" refers to the presence of identical nucleotides at the corresponding positions of two polynucleotides. When comparison is performed to obtain maximum correspondence (for example, in a comparison window), if the nucleotide sequence in two polynucleotides is identical, the polynucleotide has an "identical" sequence. The sequence comparison between two or more polynucleotides is usually performed by comparing the parts of the two sequences on a comparison window to identify and compare the local region of sequence similarity. The comparison window is typically from about 20 to 200 continuous nucleotides. The "sequence identity percentage" of a polynucleotide, such as about 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98%, 99% or 100% sequence identity, can be determined by comparing the sequences of two optimal comparisons on a comparison window, wherein for the optimal comparison of two sequences, compared with a reference sequence, the part of the polynucleotide sequence in the comparison window can include addition or deletion (that is, room). In some embodiments, the percentage is calculated by: (a) determining the number of positions where the same nucleic acid base occurs in the two sequences; (b) dividing the number of matching positions by the total number of positions in the comparison window; and (c) multiplying the result by 100. The optimal alignment of the sequences for comparison can also be performed by computerized implementation of known algorithms or by visual inspection. Easily available sequence comparison and multiple sequence alignment algorithms are the Basic Local Alignment Search Tool (BLAST) and ClustalW / ClustalW2 / Clustal Omega programs available on the Internet (e.g., the website of EMBL-EBI), respectively. Other suitable programs include, but are not limited to, GAP, BestFit, Plot Similarity, and FASTA, which are part of the Accelrys GCG software package available from Accelrys (San Diego, California, USA). See also Smith and Waterman, 1981; Needleman and Wunsch, 1970; Pearson and Lipman, 1988; Ausubel et al., 1988; and Sambrook and Russell, 2001.

[0115] The term "open reading frame" (ORF) refers to a nucleic acid sequence encoding a polypeptide. In some embodiments, an ORF comprises a translation initiation codon (i.e., a start codon), a translation termination codon (i.e., a stop codon), and a nucleic acid sequence encoding amino acids present in the polypeptide therebetween. The terms "start codon" and "stop codon" refer to a unit of three adjacent nucleotides (i.e., codons) in a coding sequence, which indicate the start and chain termination of protein synthesis (mRNA translation), respectively.

[0116] As used herein, the terms "phenotype," "phenotypic trait," or "trait" refer to one or more traits of a plant or plant cell. A phenotype is observable by the naked eye or by any other evaluation means known in the art (e.g., microscopy, biochemical analysis, or electromechanical assay). In some cases, a phenotype is directly controlled by a single gene or genetic locus (i.e., corresponding to a "monogenic trait").

[0117] In other cases, the phenotype is the result of an interaction between several genes and, in some embodiments, is also caused by the interaction of the plant and / or plant cell with its environment.

[0118] In the case of soybean maturity genes (such as E1 and E1LB), the phenotypic traits include one or more or a combination of flowering time, time after flowering, relative maturity stage, maturity time, maturity stage group, and the number of days from flowering to the onset of maturity in the soybean plant. In a specific embodiment, the phenotypic trait measured is flowering time, and includes the difference between the VE and R1 stages of the modified soybean plant relative to the control plant (see for different stages Figure 1A In another embodiment, the phenotypic trait measured is time to maturity and includes the time between the R1 and R7 stages or the R1 and R8 stages (for different stages see Figure 1A ). The number of days can vary based on the specific allele combination of the plant relative to a control plant comprising wild-type alleles at both loci.

[0119] In an exemplary embodiment of the invention, a modified soybean plant comprising a mutant E1 allele and a wild-type E1LB allele has significantly less flowering time and / or maturation time compared to a control plant, while a soybean plant comprising a mutant E1LB allele and a wild-type E1 allele has slightly less flowering time and / or maturation time compared to a control plant. In addition, a soybean plant comprising a mutant allele at both the E1 and E1LB loci has significantly less flowering time and / or maturation time compared to a control plant. The duration or degree of reduction in flowering time is further based on the nature of the mutant allele, such as based on whether the mutant allele causes a gain of function, a complete loss of function, or a partial loss of function of a gene product. In addition, the duration or degree of reduction in flowering time can be based on whether the allele is homozygous or heterozygous (e.g., biallelic), and whether the allele is homozygous recessive or dominant.

[0120] As used herein, a modified plant having a "slightly less" flowering time and / or maturity time compared to a control plant has a flowering time and / or maturity time that is between 1 day and 10 days shorter than a control plant (e.g., at least 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, 7 days, 8 days, 9 days, or 10 days shorter than a control plant. In embodiments, a modified plant has a slightly less flowering time compared to a control plant if the flowering time of the modified plant is 1-2 days, 1-3 days, 1-4 days, 1-5 days, 1-6 days, 1-7 days, 1-8 days, 1-9 days, or 1-10 days shorter than a control plant.

[0121] In contrast, a modified plant having a "significantly less" flowering time and / or maturity time compared to a control plant has a flowering time and / or maturity time that is at least 10 days shorter than a control plant, such as between 10-100 days shorter than a control plant (e.g., at least 10 days, 10-20 days 10-30 days, 10-40 days, 10-50 days, 10-60 days, 10-70 days, 10-80 days, 10-90 days or 10-100 days or any range therebetween, such as 20-30 days, 20-40 days, 30-40 days, 40-50 days, 50-60 days, 70-80 days, 80-90 days, 90-100 days, etc., shorter than a control plant).

[0122] As used herein, the term "photoperiodic response" or "photoperiodic phenomenon" refers to the physiological response of plants to the relative length of light and dark cycles. Photoperiodic responsive plants can be "short-day", "long-day" or "medium-day" plants. Photoperiodic phenomena affect flowering by inducing shoots to produce floral buds instead of leaves and lateral buds. For example, soybeans are short-day (SD) plants. In an embodiment of the present invention, the flowering time of soybeans is evaluated. Short-day plants bloom when the length of the night exceeds their critical photoperiod, and cannot bloom under short nights. Before flower development can begin, they need a continuous dark period. Natural night light (such as moonlight or lightning) does not have enough brightness or duration to interrupt flowering. Typically, short-day (i.e., long-night) plants bloom when the daylight becomes shorter (e.g., late summer and autumn in the northern hemisphere). The length of the dark period required to induce flowering is different between species and varieties of species. Long-day plants bloom when the length of the night is below their critical photoperiod. These plants typically flower as the days become longer (eg, late spring and early summer in the Northern Hemisphere).

[0123] As used herein, "flowering time" or "days to flowering" is an estimate of the duration (e.g., in hours, days, weeks, etc.) that elapses between the onset of first flowering and seed emergence. In embodiments of the present invention, the flowering time of soybean plants is modified or altered relative to control plants by introducing novel non-naturally occurring alleles in genes involved in soybean maturation (particularly E1 and / or E1Lb genes). In specific embodiments, flowering time is defined as the number of days that a soybean plant transitions from the VE stage (e.g., seed emergence, where cotyledons have penetrated the soil surface for at least 50% of the seeds) to the R1 stage (e.g., flowering onset, where at least 50% of the plants have at least one flower at any node). In specific embodiments, maturity time or post-flowering time is defined as the number of days that a soybean plant transitions from the R1 stage (e.g., flowering onset, where there is one open flower at any node on the main stem) to the R7 stage (where any pod has reached mature pod color) or from the R1 stage to the R8 stage (where 95% of the pods have reached their mature pod color). The different developmental stages of soybean plants and the colors of mature pods are described in Figure 1A and Figure 1B Provided as a reference.

[0124] As used herein, a "relative maturity group" or "relative maturity value" or "RM" can be any indicative number, symbol, or combination of the two, which provides an indication of when a plant matures. In an embodiment, a relative maturity value indicates the average number of days between flowering time and maturity time or between flowering and final seed pod reaching maturity (e.g., to the R7 stage). Similarly, changes in relative maturity groups can be associated with changes in average flowering time. As an example, in North America, a relative maturity change of one from RM 2.0 to RM 3.0 may be associated with a 10-day maturity change. This value can vary based on growth conditions (e.g., based on whether the plant is grown under short-day or long-day conditions, or based on whether the plant is grown in a greenhouse or under field conditions).

[0125] As used herein, "altered" or "modified" means an increase or decrease in maturity. In this respect, mature seeds are defined as seeds harvested in the field for commercial agricultural practices (such as sold feed). In one aspect, soybean plants are selected for expression of at least one phenotypic trait for a preferred geographical location. Phenotypic traits include altered levels of substances or molecules (such as protein, oil or gamma-linolenic acid). "Altered" can include any relative increase or decrease in the function or production of a target gene product, up to and including the complete elimination of the function or production of the gene product in one aspect. When comparing the levels of gene products, such comparisons are preferably made between organisms with similar genetic backgrounds. Preferably, a similar genetic background is a background in which the nuclear genetic material of the organisms compared has 50% or greater, more preferably 75% or greater, and even more preferably 90% or greater sequence identity. On the other hand, a similar genetic background is a background in which the plant is isogenic except for one or more markers of the present invention.

[0126] As used herein, the term "plant" may refer to a whole plant, any part thereof, or a cell or tissue culture derived from a plant. Thus, unless otherwise indicated, the term "plant" may refer to any of the following: a whole plant, a plant component or organ (e.g., leaves, stems, roots, etc.), a plant tissue, a seed, and / or a plant cell.

[0127] Plant cells are plant cells obtained from plants, or plant cells derived from cells taken from plants by culture. Thus, the term "plant cell" includes, but is not limited to, cells within seeds, suspension cultures, embryos, meristems, callus, leaves, buds, gametophytes, sporophytes, pollen, and microspores. The phrase "plant part" refers to a part of a plant, including single cells and cell tissues (such as intact plant cells in plants), cell clumps, and tissue cultures that can regenerate plants. Examples of plant parts include, but are not limited to, single cells and tissues from: pollen, ovules, leaves, embryos, roots, root tips, anthers, flowers, fruits, stems, buds, and seeds; as well as scions, rhizomes, protoplasts, callus, and the like.

[0128] As used herein, the term "primer" refers to an oligonucleotide that is capable of annealing to a nucleic acid target (in some embodiments, specifically annealing to a nucleic acid target) when placed under conditions that induce synthesis of a primer extension product (e.g., in the presence of nucleotides and an agent for polymerization (such as a DNA polymerase) and at a suitable temperature and pH) to allow a DNA polymerase and / or reverse transcriptase to attach thereto, thereby serving as a starting point for DNA synthesis. In some embodiments, one or more primers are employed to amplify plant nucleic acids (e.g., using a polymerase chain reaction; PCR).

[0129] As used herein, the term "probe" refers to a nucleic acid (e.g., a single-stranded nucleic acid or a double-stranded or higher-order nucleic acid chain, or a subsequence thereof) that can form a hydrogen-bonded duplex with a complementary sequence in a target nucleic acid sequence. Typically, the probe has a sufficient length to form a stable and sequence-specific duplex molecule with its complementary sequence, and this can be used in some embodiments to detect a target sequence present in multiple nucleic acids.

[0130] As used herein, term " offspring " and " offspring plant " refer to the plant produced by vegetative propagation or sexual reproduction from one or more parental plants.Offspring plant can be obtained by cloning a single parental plant or making a single parental plant self-pollination or by making two or more parental plants hybridize.For example, offspring plant can be obtained by cloning or self-pollination of a parental plant or by the hybridization of two parental plants, and includes self-pollinator and F1 or F2 or even more distant generations.F1 is the first generation offspring (at least one of the two parents is the donor used as the trait for the first time) produced from two parents, and the offspring of the second generation (F2) or subsequent generations (F3, F4 etc.) is the sample of self-pollination, mutual crossing, backcrossing and / or other hybridizations produced from F1, F2 etc. Therefore, F1 can be (and in some embodiments is) the hybrid produced from the hybridization between two pure breeding parents (that is, each of the pure breeding parents for the purpose trait or its allele is isozygous), and F2 can be (and in some embodiments is) the offspring produced from the self-pollination of F1 hybrid.

[0131] As used herein, phrase "recombination" refers to the exchange ("crossover") of DNA fragments between two DNA molecules or chromatids of paired chromosomes in a region of similar or identical nucleotide sequences."Recombination event" is understood herein to refer to meiotic crossovers in some embodiments.

[0132] As used herein, the term "reference sequence" refers to a defined nucleotide sequence used as a basis for nucleotide sequence comparison.

[0133] As used herein, the term "reference plant" or "control plant" refers to a defined plant used as a basis for genetic and / or phenotypic comparisons. In some embodiments, a soybean plant comprising a wild-type allele at each of the E1 and E1LB loci is a control plant for comparison to other plants comprising mutant alleles at one or both of the E1 and E1LB loci.

[0134] As used herein, the term "regeneration" and grammatical variations thereof refer to the production of plants from tissue culture.

[0135] As used herein, the phrase "stringent hybridization conditions" refers to conditions under which a polynucleotide typically hybridizes to its target subsequence (but not substantially to other sequences) in a complex mixture of nucleic acids. Stringent conditions are sequence-dependent and may be different in different circumstances.

[0136] Typically, longer sequences hybridize specifically at higher temperatures. A comprehensive guide to nucleic acid hybridization can be found in Sambrook and Russell, 2001. Typically, stringent conditions are selected to be about 5°C-10°C lower than the thermal melting point (Tm) for a specific sequence at a defined ionic strength pH. Tm is the temperature (under defined ionic strength, pH, and nucleic acid concentration) at which 50% of the probes complementary to the target hybridize to the target sequence at equilibrium (when the target sequence is present in excess, at Tm, 50% of the probes are occupied at equilibrium). Exemplary stringent conditions are those wherein the salt concentration is less than about 1.0 M sodium ions, typically about 0.01 to 1.0 M sodium ion concentration (or other salts) at pH 7.0 to 8.3, and the temperature is at least about 30°C for short probes (e.g., 10 to 50 nucleotides) and at least about 60°C for long probes (e.g., greater than 50 nucleotides).

[0137] Stringent conditions can also be achieved by adding destabilizing agents such as formamide. Additional exemplary stringent hybridization conditions include 50% formamide, 5×SSC, and 1% SDS, incubated at 42° C.; or SSC, 1% SDS, incubated at 65° C.; at 65° C., washed once or multiple times in 0.2×SSC and 0.1% SDS. For PCR, a temperature of about 36° C. is typically used for low stringency amplification, but the annealing temperature can vary between about 32° C. and 48° C. (or higher) depending on the primer length. Additional guidance for determining hybridization parameters is provided in many references (see, e.g., Ausubel et al., 1999).

[0138] As used herein, the term "trait" refers to a phenotype of interest, a gene that contributes to a phenotype of interest, and a nucleic acid sequence associated with a gene that contributes to a phenotype of interest. For example, a "soybean maturity trait" refers to a phenotype and a gene (e.g., E1 or E1LB) that contributes to soybean maturity and has a nucleic acid sequence (e.g., soybean maturity-related gene product) associated with a photoperiod response, including the number of days between flowering and pod formation.

[0139] As used herein, the term "transgenic" refers to a nucleic acid molecule introduced into an organism or one or more of its ancestors by some form of artificial transfer technology. Therefore, artificial transfer technology creates a "transgenic organism" or "transgenic cell". It should be understood that artificial transfer technology can occur in an ancestral organism (or a cell therein and / or a cell that can develop into an ancestral organism), and even if one or more natural and / or assisted breeding results in the presence of an artificially transferred nucleic acid molecule in an offspring individual, any offspring individual with an artificially transferred nucleic acid molecule or a fragment thereof is still considered to be transgenic.

[0140] As used herein, the term "targeted mutagenesis" or "mutagenesis strategy" refers to any mutagenesis method that results in the intentional mutagenesis of a selected gene. Targeted mutagenesis includes CRISPR, TILLING, TALEN methods, and other methods that have not yet been discovered but can be used to achieve the same results. DETAILED DESCRIPTION

[0141] Soybean is a short-day (SD) plant that grows in a wide range of geographic regions and latitudes from the equator up to 50 degrees. This wide adaptability is most likely generated by genetic diversity at a large number of major genes and quantitative trait loci that control flowering behavior.

[0142] Photoperiod is one of the main climatic factors that determines soybean flower development and adaptability to different regions. Short day lengths can accelerate flowering, while long day lengths can delay flowering. Due to their photoperiod sensitivity, the cultivation area of ​​each soybean cultivar is restricted to a very narrow range of latitudes to achieve its highest yield.

[0143] Provided herein are plants comprising a non-natural allele combination of soybean maturity genes (particularly at E1 and E1LB loci), which modifies the flowering characteristics (e.g., flowering time and / or maturity value) of the resulting plants. In some cases, when the alleles are expressed in a plant or part thereof, the allele combination produces modified soybean maturity characteristics compared to a control plant (such as a control plant comprising a wild-type allele at one or two loci) that does not comprise a given allele combination. Due to the modified flowering characteristics, the resulting soybean plant and its offspring plants can be cultivated and grown in a wider range of latitudes, thereby achieving higher yields. The terms "soybean maturity" and "relative maturity" and "photoperiod response" are used interchangeably herein. Various methods of introducing mutations that cause non-natural alleles and allele combinations into soybean plants are also disclosed, including transgenic methods, gene editing, and breeding. Markers for identifying the presence of these non-natural alleles in plants are also disclosed. As used herein, the term "phenotype," "phenotypic trait," or "trait" refers to one or more distinguishable characteristics of a genetically controlled trait.

[0144] In certain embodiments, the plant provided herein is a non-natural soybean variety with a desired trait. In a specific embodiment, the non-natural soybean variety is a improved soybean variety. "Non-natural soybean variety" is soybean of any variety not present in nature. "Non-natural soybean variety" can be produced by any method known in the art, including but not limited to transformation of soybean plants or germplasm, transfection of soybean plants or germplasm and hybridization of naturally occurring soybean varieties with non-natural soybean varieties. In certain embodiments, "non-natural soybean varieties" can include one or more heterologous nucleotide sequences. In certain embodiments, "non-natural soybean varieties" can include one or more non-natural alleles of naturally occurring genes (i.e., non-natural mutations are introduced into genes naturally present in soybeans). In certain embodiments, "non-natural soybean varieties" can include non-natural combinations of one or more non-natural alleles of soybean maturity genes (i.e., non-natural alleles of E1 and E1LB genes are in different combinations that are not naturally present in the same soybean).

[0145] A "subject plant or plant cell" is a plant or plant cell that has been subjected to a genetic alteration (e.g., a mutation) in a gene of interest to produce a non-naturally occurring and novel allele, or a plant or plant cell that is inherited from and contains the alteration in a plant or cell so altered. A "control" or "control plant" or "control plant cell" provides a reference point for measuring changes in the phenotype of a subject plant or plant cell. Control plants or plant cells may include, for example: (a) wild-type plants or cells, i.e., plants or cells having the same genotype as the starting material used to cause the genetic alteration of the subject plant or cell; (b) plants or plant cells having the same genotype as the starting material but having wild-type alleles at both the E1 and E1LB loci; (c) plants or plant cells having the same genotype as the starting material but having wild-type alleles at the E1 or E1LB loci; (d) plants or plant cells that are non-transformed segregants among the progeny of the subject plant or plant cell; (e) plants or plant cells that are genetically identical to the subject plant or plant cell but have not been exposed to conditions or stimuli that would induce expression of the gene or allele of interest; or (f) the subject plant or plant cell itself under conditions in which the gene or allele of interest is not expressed.

[0146] I. Novel Non-naturally Occurring El Gene Alleles Leading to Modified Flowering Time in Soybean

[0147] Methods and compositions for producing soybean plants with modified flowering characteristics are provided. Such plants contain non-naturally occurring alleles at one or both of the E1 locus and the E1LB locus. These plants can be grown in geographic regions (including latitudinal regions) outside of the restricted region when no allele combination is introduced (e.g., relative to plants containing any two wild-type alleles). In addition to expanding the range of cultivation, the yield of the plants is also increased.

[0148] Site-directed mutagenesis is performed at the E1 and E1Lb loci, followed by selection of alleles encoding mutant forms of the E1 and E1Lb proteins with reduced activity. Such alleles can be used to prepare soybean plants with altered flowering times. The novel E1 and E1Lb alleles thus generated are particularly suitable for the context of in situ mutant (genome-edited) plants that can be grown at latitudes other than their non-mutated counterparts.

[0149] Non-limiting examples of allele combinations resulting from the non-naturally occurring alleles described herein include:

[0150] (i) a mutant E1LB allele resulting in partial expression of the E1LB protein and a wild-type E1 allele;

[0151] (ii) mutant E1LB alleles resulting in loss of E1LB protein expression and wild-type E1 alleles;

[0152] (iii) a mutant E1LB allele resulting in partial expression of the E1LB protein and a mutant E1 allele resulting in partial expression of the E1 protein;

[0153] (iv) mutant E1LB alleles resulting in loss of expression of the E1LB protein and mutant E1 alleles resulting in partial expression of the E1 protein;

[0154] (v) mutant E1LB alleles resulting in partial expression of E1LB protein and mutant E1 alleles resulting in loss of expression of E1 protein; and

[0155] (vi) a mutant E1LB allele resulting in loss of expression of the E1LB protein and a mutant E1 allele resulting in loss of expression of the E1 protein.

[0156] (vii) a mutant E1 allele resulting in partial expression of the E1 protein and a wild-type E1LB allele;

[0157] (viii) a mutant E1 allele resulting in loss of E1 protein expression and a wild-type E1 allele.

[0158] The flowering time of a soybean plant comprising any of the above allele combinations is modified relative to a control plant.In specific embodiments, the control plant comprises a wild-type E1 allele and a wild-type E1LB allele.

[0159] (a) E1 gene and its novel alleles

[0160] A large number of QTLs involved in flowering and maturity have been identified in different linkage groups. Among them, 11 have been confirmed as major effect QTLs controlling flowering time and maturity in soybean: E1 and E2, E3, E4, E6, E7, E8, E9, E10, qDTF-J1 and J. The genes underlying QTLs E1-E4, E9, E10, qDTF-J1 have been identified and their functions in photoperiodic control of flowering have been characterized. Among these genes, E1-E4 are the four major loci associated with flowering time (FT) and maturity.

[0161] E1 is a major gene associated with flowering time and maturity and is located in the near-centromeric region. The E1 gene (SEQID NO: 1) is intronless and encodes an E1 protein (SEQID NO: 2), which contains a putative two-component nuclear localization signal (NLS) and a domain (B3-like domain) distantly related to the plant-specific B3 domain (Xia, ZJ et al. Proc Natl Acad Sci USA. [Proceedings of the National Academy of Sciences of the United States] 109, E2155-E2164 (2012)). E1 is a transcription factor. E1 is considered to be a contributor to flowering time variation in soybean cultivars. In addition to having an effect on post-flowering responses, E1 also has an effect on pre-flowering development.

[0162] The E1 gene includes at least 4 alleles of natural variation, with E1 and e1-as as two basic genotypes. Known natural E1 recessive allele variations in soybean varieties include e1-as, e1-fs, e1-nl and e1-b3a (Zhai, H. et al. PLoS One. [Public Science Library 1] 9 (5), e97636 (2014)). e1-as includes a single missense point mutation in the nuclear localization signal region, which leads to a leaky allele. This one amino acid change leads to a change in cellular localization and the e1 protein is distributed in both the nucleus and the cytoplasm. However, e1-as is a leaky allele and has a partial function of delaying flowering (Xia, 2013).

[0163] The other three non-functional alleles are e1-fs, e1-nl and e1-b3a. e1-fs has a 1bp deletion in the B3 domain, and the frameshift mutation produces a premature stop codon and a truncated protein encoding 41 amino acids. e1-nl is an invalid allele and all E1 genes are missing. e1-b3a allele has 3 SNPs and 2bp deletions (causing frameshift mutations) in the B3 domain. E1-nl is an invalid allele with about 130kb deletions containing the E1 gene. e1-b3a contains a 2bp deletion in the middle of the B3 domain. e1-as is obviously a leaky allele and, contrary to the functional e1-fs and e1-nl, partially inhibits soybean flowering.

[0164] E1 was expressed in a dual mode, with higher expression under long-day (LD) conditions than under short-day (SD) conditions. E1 is a putative transcription factor (TF) that negatively controls GmFT2a and GmFT5a to delay flowering in the context of functional PHYA genes (E3, E4) and LD conditions (Lin, X. et al. Molecular mechanisms for the photoperiodic regulation of flowering in soybean. J. Integr. Plant Biol. (2021) 63:981-994; Xia, Z. et al. Positional cloning and characterization reveal the molecular basis for soybean maturity locus E1 that regulates photoperiodic flowering. Proc. Natl. Acad. Sci. USA (2021) 109:E2155-2164; Zhai, H. et al. Diurnal expression pattern, allelic variation, and association analysis reveal functional features of the E1 gene in [Diurnal expression patterns, allelic variation, and correlation analysis reveal functional characteristics of the E1 gene in controlling photoperiodic flowering in soybean]. PloS One (2015) 10(8), e0135909. doi:10.1371 / journal.pone.0135909).

[0165] As used herein, E1 activity refers to the effect of E1 protein on flowering time and / or maturity time. An allele that results in complete loss of function encodes a mutant E1 protein that has no E1 activity. An allele that results in partial loss of function encodes a mutant E1 protein that has reduced E1 activity relative to the wild-type, unmutated E1 protein.

[0166] The present invention discloses novel E1 alleles produced using mutagenesis and genome editing techniques. Novel alleles are produced using the deletion and / or substitution of bases at the position corresponding to the wild-type allele identified. Example alleles comprising non-natural mutations in the E1 gene are provided in SEQ ID NO: 5, 7, 9, 11 and 13, encoding the corresponding mutant E1 proteins provided in SEQ ID NO: 6, 8, 10, 12 and 14. At least some non-natural alleles (e.g., SEQ ID NO: 5, 7 and 9) cause the mutated E1 protein to not have E1 activity. At least some non-natural alleles (e.g., SEQ ID NO: 11 and 13) cause the mutated E1 protein to have reduced or limited E1 activity.

[0167] (b) E1Lb gene and its novel alleles

[0168] Similar to E1, two E1 orthologs, namely E1La (Glyma.04G156400.1) and E1Lb (Glyma.04G143300.1), can control the onset of flowering. (Xu, M. et al. Plant Physiol. [Plant Physiology] 168, 1735-1746 (2015)). The functions of these genes in flowering are similar to those of E1, and virus-induced silencing of E1La and E1Lb was found to upregulate the expression of FT2a and FT5a and lead to early flowering. In both the e3 / E4 and E3 / E4 genetic backgrounds, the natural loss-of-function allele (E1Lb) showed upregulated expression of FT2a and FT5a and flowered earlier than those of E1Lb under long-day conditions. E1Lb delays flowering under long-day conditions by inhibiting the expression of FT2a and FT5a independently of E1.

[0169] As used herein, E1Lb activity refers to the effect of the E1Lb protein on flowering time and / or maturity time. An allele that causes a complete loss of function encodes a mutant E1Lb protein that has no E1Lb activity. An allele that causes a partial loss of function encodes a mutant E1Lb protein that has reduced E1Lb activity relative to the wild-type, unmutated E1 protein.

[0170] The present invention discloses novel E1Lb alleles generated using mutagenesis and genome editing techniques. Novel alleles are generated using deletions and / or substitutions of bases at positions corresponding to wild-type alleles identified. Exemplary alleles comprising non-natural mutations in the E1Lb gene are provided in SEQ ID NOs: 15, 17, 19, 21, and 23, encoding corresponding mutant E1Lb proteins provided in SEQ ID NOs: 16, 18, 20, 22, and 24. At least some of the non-natural alleles (e.g., SEQ ID NOs: 15 and 17) result in mutated E1Lb proteins that do not have E1Lb activity. At least some of the non-natural alleles (e.g., SEQ ID NOs: 19, 21, and 23) result in mutated E1Lb proteins that have reduced or limited E1 activity.

[0171] In the context of nucleic acid sequences, the term "corresponding to" means that when the nucleic acid sequences of certain sequences are aligned with each other, the nucleic acids "corresponding to" certain enumerated positions in the present invention are those that are aligned with these positions in the reference sequence, but are not necessarily located in these precise numerical positions relative to the specific nucleic acid sequence of the present invention. For example, an E1 allele produced by a mutation comprising an 8bp deletion at nucleotides 147 to 154 corresponds to a gap of eight base pairs in the mutant allele that overlaps with nucleotides 147 to 154 of the wild-type allele when the nucleotide sequence of the wild-type allele is aligned with the nucleotide sequence of the mutant allele. In other words, the mutant allele overlaps with the wild-type allele before and excluding position 147 and after and excluding position 154. An example alignment of a wild-type allele and a corresponding novel allele is shown in Figure 4A and Figure 5A middle.

[0172] The best alignment of the sequence for comparison can be performed by computerized implementation of known algorithms or by visual inspection. Easily available sequence comparison and multiple sequence alignment algorithms are the basic local alignment search tool (BLAST) and ClustalW / ClustalW2 / Clustal Omega programs available on the Internet (e.g., the website of EMBL-EBI), respectively. Other suitable programs include, but are not limited to, GAP, BestFit, Plot Similarity, and FASTA, which are part of the Accelrys GCG software package available from Accelrys (San Diego, California, USA). See also Smith and Waterman, 1981; Needleman and Wunsch, 1970; Pearson and Lipman, 1988; Ausubel et al., 1988; and Sambrook and Russell, 2001.

[0173] In some embodiments, the alleles result in variants and fragments of the E1 and E1Lb proteins described above, and when expressed in a plant, plant part or seed, the variants and fragments result in modified flowering time characteristics.

[0174] When expressed in plants, plant parts or seeds, alleles that result in E1 or E1Lb protein fragments that modify flowering time characteristics include those that are shorter than the full-length sequence, due to the use of alternative downstream start sites, or due to processing to produce a shorter protein that is active. Alleles encoding protein fragments that modify flowering time characteristics when expressed in plants can be polypeptides such as 10, 25, 50, 100, 150, 200, 250 or more amino acids in length of any of SEQ ID NO: 2 or 4. As used herein, a fragment comprises at least 8 consecutive amino acids of SEQ ID NO: 2 or 4.

[0175] Unless otherwise indicated, identity and similarity are calculated using the Needleman-Wunsch global alignment and scoring algorithms (Needleman and Wunsch (1970) J. Mol. Biol. 48(3):443-453), as implemented in the EMBOSS software package (Rice, P., Longden, I., and Bleasby, A., EMBOSS: The European Molecular Biology Open Software Suite, 2000, Trends in Genetics 16, (6) pp. 276-277, version 6.3.1, available at embnet.org / resource / emboss The method of comparing sequences of the present invention is implemented by the "needle" program distributed as part of EMBOSS (obtained from EMBnet and other sources on andemboss.sourceforge.net), which uses default gap penalties and scoring matrices (EBLOSUM62 for proteins and EDNAFULL for DNA). Equivalent programs may also be used. An "equivalent program" refers to any sequence comparison program that generates an alignment with identical nucleotide residue matches and identical percentages of sequence identity for any two sequences in question when compared to the corresponding alignment generated by needle of EMBOSS version 6.3.1.

[0176] Additional mathematical algorithms are known in the art and can be used to compare two sequences. See, for example, the algorithm of Karlin and Altschul (1990) Proc. Natl. Acad. Sci. USA 87:2264, which was modified in Karlin and Altschul (1993) Proc. Natl. Acad. Sci. USA 90:5873-5877. Such an algorithm is incorporated into the BLAST program of Altschul et al. (1990) J. Mol. Biol. 215:403. BLAST nucleotide searches can be performed using the BLASTN program (searching nucleotide queries against nucleotide sequences) to obtain nucleotide sequences homologous to the nucleic acid molecules of the invention, or using the BLASTX program (searching translated nucleotide queries against protein sequences) to obtain protein sequences homologous to the nucleic acid molecules of the invention. BLAST protein searches can be performed using the following programs: using the BLASTP program (searching protein queries for protein sequences) to obtain amino acid sequences homologous to protein molecules of the present invention, or using the TBLASTN program (searching protein queries for translated nucleotide sequences) to obtain nucleotide sequences homologous to protein molecules of the present invention. In order to obtain gapped alignments for comparison purposes, Gapped BLAST (in BLAST 2.0) as described in Altschul et al. (1997) Nucleic Acids Res. [Nucleic Acids Research] 25:3389 can be used. Alternatively, PSI-Blast can be used for iterative searches, which detect distant relationships between molecules. See Altschul et al. (1997) supra. When using BLAST, Gapped BLAST, and PSI-Blast programs, the default parameters of the corresponding programs (e.g., BLASTX and BLASTN) can be used. Alignment can also be performed manually by inspection.

[0177] Two sequences are "optimally aligned" when they are aligned for similarity scoring using a defined amino acid substitution matrix (e.g., BLOSUM62), a gap existence penalty, and a gap extension penalty (to achieve the highest score possible for the pair of sequences). Amino acid substitution matrices and their use in quantifying the similarity between two sequences are well known in the art and are described, for example, in Dayhoff et al. (1978) "A model of evolutionary change in proteins". In "Atlas of Protein Sequence and Structure", Vol. 5, Supplement 3 (Edited by MO Dayhoff), pp. 345-352. Natl. Biomed. Res. Found., Washington, DC and Hemkoff et al. (1992) Proc. Natl. Acad. Sci. USA 89: 10915-10919. The BLOSUM62 matrix is ​​usually used as a default scoring substitution matrix in sequence alignment schemes. For introducing a single amino acid gap in one of the aligned sequences, a gap existence penalty is applied, and for each other empty amino acid position inserted in the gap that has been opened, a gap extension penalty is applied. The comparison is limited by the amino acid position of each sequence at the beginning and end of the comparison, and optionally limited by inserting a gap or multiple gaps in one or both sequences to reach the highest possible score. Although the best comparison and scoring can be completed manually, the process is assisted by using a computer-implemented comparison algorithm, which is, for example, described in Altschul et al. (1997) Nucleic Acids Res. [nucleic acid research] 25: gapped BLAST 2.0 that the public can obtain on the website of the National Center for Biotechnology Information (www.ncbi.nlm.nih.gov). Optimal alignments, including multiple alignments, can be prepared using, for example, PSI-BLAST, which is available through www.ncbi.nlm.nih.gov and described by Altschul et al. (1997) Nucleic Acids Res. 25:3389-3402.

[0178] II. Gene Editing

[0179] The flowering time-related sequences provided herein (i.e., E1 and E1LB) can be targeted to the genome of the recipient plant cell to generate a novel allele sequence. Such methods include, but are not limited to, meganucleases designed for the target plant genome sequence CRISPR-Cas9, TALEN, and other technologies for precise genome editing (Feng et al. Cell Research [Cell Research] 23: 1229-1232, 2013, WO 2013 / 026740); Cre-lox site-specific recombination; FLP-FRT recombination (Li et al. (2009) Plant Physiol [Plant Physiology] 151: 1087-1095); Bxbl-mediated integration (Yau et al. Plant J [Plant Journal] (2011) 701: 147-166); zinc finger-mediated integration (Wright et al. (2005) Plant J [Plant Journal] 44: 693-705; Cai et al. (2009) Plant Mol. Biol [Plant Mol. Biol] 69:699-709); and homologous recombination (Lieberman-Lazarovich and Levy (2011) Methods Mol Biol [Molecular Biology Methods]: 51-65); primer editing and transposases (Anzalone, A. et al., Nat Biotechnol. [Nature Biotechnology] 2020 Jul; 38(7): 824-844); translocations; and inversions.

[0180] Various embodiments of the methods described herein use gene editing. In certain embodiments, gene editing is used to mutagenesis the genome of a plant to produce a plant with a novel E1 allele and / or novel E1Lb allele that imparts a modified flowering time. The novel allele can be produced by targeted introduction of mutations at E1 and / or E1Lb loci in the plant genome. In a specific embodiment, editing is included in the introduction of mutations (e.g., insertions, deletions, frameshifts, etc.) at the nuclear localization signal (NLS) at the E1 loci and E1LB loci. In this study, a point mutation from arginine to threonine at position 15 in E1 happens to occur at the first basic domain of KKRK (which is changed to KKTK) in the two-component NLS, resulting in a subcellular distribution different from E1 and e1-as. This leads to the inventors believing that the second basic domain may have a similar effect in the distribution of E1 proteins. In a specific embodiment, editing is included in the introduction of mutations (e.g., insertions, deletions, frameshifts, etc.) at the basic domain of the NLS at the E1 loci and / or E1LB loci. In specific embodiments, the editing comprises introducing a mutation at the second basic domain of the two basic domains of the NLS at the E1 locus and the E1LB locus, wherein the second basic domain is downstream relative to the first basic domain of the NLS.

[0181] Editing can be achieved by using an editing expression cassette. The expression cassette will be included in the transcription and translation initiation region (i.e., promoter), the target polynucleotide, and the transcription and translation termination region (i.e., termination region) that work in the target organism (i.e., plant or bacteria) in the 5'-3' transcription direction. The promoter of the present invention can guide or drive the transcription and expression of the coding sequence in the host cell. The regulatory region (i.e., promoter, transcription regulatory region, and translation termination region) can be endogenous or heterologous to the host cell or to each other. As used herein, a chimeric gene or chimeric nucleic acid molecule comprises a coding sequence operably connected to a transcription initiation region, and the transcription initiation region is heterologous to the coding sequence.

[0182] A variety of transcription terminators can be used for use in expression cassettes. These transcription terminators are responsible for transcription termination and correct mRNA polyadenylation beyond transgenic. The terminator region can be natural with the transcription initiation region, can be natural with the DNA sequence operably connected with the purpose, can be natural with the host plant, or can be derived from another source (that is, it is foreign or heterologous to promoter, target DNA sequence, host plant, or any combination thereof). Suitable transcription terminators are those known to play a role in plants, and include CAMV pSOY1 terminator, tml terminator, nopaline synthase terminator, and pea rbcs E9 terminator. These terminators can be used in both monocotyledons and dicotyledons. In addition, the natural transcription terminator of gene can be used. The terminator region used in the expression cassette can be obtained from, for example, the Ti-plasmid of Agrobacterium tumefaciens, such as octopine synthase and nopaline synthase terminator region. See also Guerineau et al. (1991) Mol. Gen. Genet. 262:141-144; Proudfoot (1991) Cell 64:671-674; Sanfacon et al. (1991) Genes Dev. 5:141-149; Mogen et al. (1990) Plant Cell 2:1261-1272; Munroe et al. (1990) Gene 91:151-158; Ballas et al. (1989) Nucleic Acids Res. 17:7891-7903; and Joshi et al. (1987) Nucleic Acid Res. 15:9627-9639.

[0183] Additional regulatory signals include, but are not limited to, transcription initiation start sites, operators, activators, enhancers, other regulatory elements, ribosome binding sites, initiation codons, termination signals, etc. See, e.g., U.S. Pat. Nos. 5,039,523 and 4,853,331; EPO 0480762A2; Sambrook et al. (1992) Molecular Cloning: A Laboratory Manual, Maniatis et al., eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY), hereinafter "Sambrook 11"; Davis et al., eds., (1980).

[0184] In preparing the expression cassette, the various DNA fragments may be manipulated to provide a DNA sequence in the proper orientation and, if appropriate, in the proper reading frame. To this end, adapters or linkers may be employed to join the DNA fragments, or other manipulations may be involved to provide convenient restriction sites, remove excess DNA, remove restriction sites, etc. For this purpose, in vitro mutagenesis, primer repair, restriction, annealing, resubstitution (e.g., conversion and transversion) may be involved.

[0185] Many promoters can be used in the practice of the present invention. Promoters can be selected according to the desired results. Nucleic acids can be combined with constitutive, inducible, tissue-preferred or other promoters for expression in the target organism. See, for example, the promoters shown in WO99 / 43838 and U.S. Patent Nos.: 8,575,425; 7,790,846; 8,147,856; 8.586832; 7,772,369; 7,534,939; 6,072,050; 5,659,026; 5,608,149; 5,608,144; 5,604,121; 5,569,597; 5,466,785; 5,399,680; 5,268,463; 5,608,142; and 6,177,611; which are incorporated herein by reference. In some embodiments, promoters used herein include exogenous promoters. The term "exogenous promoter" refers to a promoter that is not found in plants in nature, such as a synthetic promoter.

[0186] In some embodiments, provided herein are plants transformed with and expressing a gene editing machine as described above, which, when crossed with a target plant, allow gene editing to occur in the target plant.

[0187] In general, gene editing may involve transient, inducible, or constitutive expression of a gene editing component or system. Gene editing may involve genomic integration or episomal presence of a gene editing component or system.

[0188] Gene editing generally refers to the use of site-directed nucleases (including but not limited to CRISPR / Cas, zinc fingers, meganucleases, etc.) to shorten nucleotide sequences at desired locations. This may result in insertion / deletion ("indel") mutations (i.e., "SDN1"), base editing (i.e., "SDN2"), or allele insertion or substitution (i.e., "SDN3"). SDN2 or SDN3 gene editing may include providing one or more recombination templates (e.g., in a vector) comprising a target gene sequence (i.e., to be introduced into a plant genome) that can be used for homology-directed repair (HDR) in plants. In some embodiments, the target gene or allele is a gene or allele that can confer improved traits (e.g., modified flowering time characteristics) to plants. The recombination template may be introduced into the plant, and the donor plant comprising the recombination template may be edited by transformation or by breeding. The break in the plant genome may be introduced into the interior, upstream, and / or downstream of the target sequence. In some embodiments, double-stranded DNA breaks are generated within or near the target sequence locus. In some embodiments, breaks are generated upstream and downstream of the target sequence locus, which may result in its excision from the genome. In some embodiments, one or more single-stranded DNA breaks (nicks) are generated inside, upstream and / or downstream of the target sequence (e.g., using a nickase Cas9 variant). Any of these DNA breaks, as well as those introduced by other methods known to those skilled in the art, can induce HDR. Through HDR, the target sequence is replaced by the sequence of a provided recombination template, which comprises a target allele, such as SEQ ID NO: 1, 2, or a polynucleotide encoding a polypeptide having a sequence of any one of SEQ ID NO: 2, 4 can be provided on the template / as a template. By designing the system, one or more single-stranded or double-stranded breaks are introduced into the interior, upstream and / or downstream of the corresponding region in the plant genome that does not contain the target gene sequence, and the region can be replaced with a template.

[0189] In an embodiment, the site-directed nuclease is selected from the group consisting of: a mega nuclease (MN), a zinc finger nuclease (ZFN), a transcription activator-like effector nuclease (TALEN), a Cas9 nuclease, a Cfp1 nuclease, a dCas9-Fok1, a dCpf1-Fok1, a chimeric Cas9-cytidine deaminase, a chimeric Cas9-adenine deaminase, a chimeric FEN1-Fok1, and Mega-TAL, a nickase Cas9 (nCas9), a chimeric dCas9 non-Fok1 nuclease, and a dCpf1 non-Fok1 nuclease.

[0190] In an embodiment, editing is performed by transforming a plant cell with an expression cassette, the expression cassette comprising (i) a nucleic acid encoding a site-directed nuclease; and (ii) a nucleic acid encoding at least one guide RNA (gRNA) for a target sequence. The gRNA is directed to a target sequence comprising a nuclear localization sequence (NLS) at the E1 locus and / or the E1LB locus. In a specific embodiment, the gRNA is directed to a target sequence comprising a second basic domain of a nuclear localization sequence (NLS) at the E1 locus and / or the E1LB locus. In an embodiment of editing an expression cassette, the nucleic acid encoding the site-directed nuclease is operably linked to a first promoter, and the nucleic acid encoding the at least one gRNA is operably linked to a second promoter (which may be the same or different from the first promoter). In some embodiments, the expression cassette may further comprise one or more additional regulatory elements, such as an enhancer operably linked to the first promoter or the second promoter.

[0191] In certain embodiments, the target gene described herein or the mutation in the wild-type allele can be produced by introducing DNA double-strand breaks via targeting without using a recombinant template. Such a break can be repaired by a non-homologous end joining (NHEJ) process, which may result in a small insertion or deletion (indel) at the repair site. Such indels may result in frameshift mutations, thereby causing premature termination codons or other types of functional loss mutations in the targeted gene.

[0192] In some embodiments, gene editing may involve transient, inducible, or constitutive expression of a gene editing component or system in a target plant. Gene editing may also involve genomic integration or episomal presence of a gene editing component or system in a target plant.

[0193] In certain embodiments, nucleic acid modification or mutation is achieved by a (modified) zinc finger nuclease (ZFN) system. The ZFN system uses an artificial restriction endonuclease generated by fusing a zinc finger DNA binding domain with a DNA cleavage domain that can be engineered to target a desired DNA sequence. Exemplary methods for genome editing using ZFNs can be found, for example, in the following: U.S. Patent Nos. 6,534,261; 6,607,882; 6,746,838; 6,794,136; 6,824,978; 6,866,997; 6,933,113; and 6,979,539.

[0194] In certain embodiments, nucleic acid modification is achieved by (modified) meganucleases, which are endodeoxyribonucleases characterized by large recognition sites (double-stranded DNA sequences of 12 to 40 base pairs). Exemplary methods using meganucleases can be found in: U.S. Patent Nos.: 8,163,514; 8,133,697; 8,021,867; 8,119,361; 8,119,381; 8,124,369; and 8,129,134, which are specifically incorporated by reference.

[0195] In certain embodiments, nucleic acid modification is achieved by a (modified) CRISPR / Cas complex or system. In certain embodiments, the CRISPR / Cas system or complex is a Class 2 CRISPR / Cas system. In certain embodiments, the CRISPR / Cas system or complex is a Type II, Type V or Type VI CRISPR / Cas system or complex. Instead of generating customized proteins to target specific sequences, the CRISPR / Cas system can program a single Cas protein to recognize a specific nucleic acid target via an RNA guide sequence (gRNA). In other words, the short RNA guide sequence can be used to recruit the Cas enzyme protein to a specific nucleic acid target locus of interest (which may contain or consist of RNA and / or DNA).

[0196] Typically, CRISPR / Cas or CRISPR systems, as used herein in the above-mentioned documents, collectively refer to transcripts and other elements involved in the expression of CRISPR-related ("Cas") genes or directing their activity, including sequences encoding Cas genes and one or more of the following: tracr (trans-activating CRISPR) sequences (e.g., tracrRNA or active partial tracrRNA), tracr-pairing sequences (including "direct repeat sequences" and partial direct repeat sequences processed by tracrRNA in the context of endogenous CRISPR systems), guide sequences (also referred to as "spacers" in the context of endogenous CRISPR systems), or one or more "RNAs" as used herein (e.g., one or more RNAs for guiding Cas such as Cas9, such as CRISPR RNA and, where applicable, trans-activating (tracr) RNA or single guide RNA (sgRNA) (chimeric RNA)) or other sequences and transcripts from CRISPR loci. Typically, CRISPR systems are characterized by elements that promote the formation of CRISPR complexes at the site of the target sequence (also referred to as prototype spacers in the context of endogenous CRISPR systems). In the context of forming a CRISPR complex, a "target sequence" refers to a sequence to which a guide sequence is designed to have complementarity, wherein hybridization between the target sequence and the guide sequence promotes formation of a CRISPR complex. The target sequence may comprise any polynucleotide, such as a DNA or RNA polynucleotide.

[0197] In certain embodiments, gRNA is a chimeric guide RNA or a single guide RNA (sgRNA). In certain embodiments, gRNA comprises a guide sequence and a tracr pairing sequence (or a co-directional repeat sequence). In certain embodiments, gRNA comprises a guide sequence, a tracr pairing sequence (or a co-directional repeat sequence) and a tracr sequence. In certain embodiments, a CRISPR / Cas system or complex as described herein does not include and / or does not rely on the presence of a tracr sequence (e.g., if the Cas protein is Cas12a).

[0198] As mentioned herein, Cas proteins, such as but not limited to Cas9, Cas12a (formerly known as Cpf1), Cas12b (formerly known as C2c1), Cas13a (formerly known as C2c2), C2c3, Cas13b proteins, can be derived from any suitable source and can therefore include different orthologs from a variety of (prokaryotic) organisms, as well documented in the art. In certain embodiments, the Cas protein is a (modified) Cas9, preferably a (modified) Staphylococcus aureus Cas9 (SaCas9) or a (modified) Streptococcus pyogenes Cas9 (SpCas9). In certain embodiments, the Cas protein is Cas12a, optionally from an aminoacidococcus species, such as an aminoacidococcus species BV3L6 Cpf1 (AsCas12a), or a Lachnospiraceae Cas12a, such as Lachnospiraceae MA2020 or Lachnospiraceae MD2006 (LBCas12a). See U.S. Patent No. 10,669,540, which is incorporated herein by reference in its entirety. Alternatively, the Cas12a protein may be from Moraxella bovoculi AAX08_00205 [Mb2Cas12a] or Moraxella bovoculi AAX11_00205 [Mb3Cas12a]. See, WO 2017 / 189308, which is incorporated herein by reference in its entirety. In certain embodiments, the Cas protein is (modified) C2c2, preferably Leptotrichia wadei C2c2 (LwC2c2) or Listeria newyorkensis FSL M6-0635 C2c2 (LbFSLC2c2). In certain embodiments, the (modified) Cas protein is C2c1. In certain embodiments, the (modified) Cas protein is C2c3. In certain embodiments, the (modified) Cas protein is Cas13b. Other Cas enzymes are available to those skilled in the art.

[0199] Gene editing methods and compositions are also disclosed in U.S. Pat. Nos. 10,519,456 and 10,285,348 82, the entire contents of which are incorporated herein by reference.

[0200] The gene editing machine (e.g., DNA modification enzyme) introduced into the plant can be controlled by any promoter capable of driving the recombinant gene to be expressed in the plant. In some embodiments, the promoter is a constitutive promoter. In some embodiments, the promoter is a tissue-specific promoter, such as a pollen-specific promoter or a sperm cell-specific promoter, a zygote-specific promoter, or a promoter (e.g., prOsActin1) highly expressed in sperm, ovum, and zygote. Suitable promoters are disclosed in U.S. Patent No. 10,519,456, the entire contents of which are incorporated herein by reference.

[0201] In another aspect, provided herein is a method for editing plant genomic DNA. In some embodiments, the method comprises pollinating a target plant comprising genomic DNA to be edited using a first soybean plant expressing a DNA modification enzyme and at least one optional guide nucleic acid as described above. In some embodiments, the method for generating novel alleles and allele combinations comprises editing at one or more of the E1 locus and / or the E1LB locus of the soybean plant genome via a site-directed nuclease.

[0202] III. Selection of plants with novel alleles and improved traits.

[0203] In addition to phenotypic traits, the genetic characteristics of plants represented by genetic marker characteristics can be used to select plants with desired traits. The term "marker-based selection" refers to the use of genetic markers to detect one or more nucleic acids from plants, wherein the nucleic acid is associated with the desired trait, to identify the gene or allele carrying the desired (or undesirable) trait. Plants. Markers include, but are not limited to, restriction fragment length polymorphism (RFLP), random amplified polymorphic DNA (RAPD), random primer polymerase chain reaction (AP-PCR), DNA amplification fingerprint analysis (DAF), sequence signature amplification region (SCAR), amplified fragment length polymorphism (AFLP), simple sequence repeat (SSR) (also referred to as microsatellite) and single nucleotide polymorphism (SNP). It is known that a series of public markers are being studied by ASTA and other industry organizations according to the U.S. Plant Variety Protection Act to study its suitability in standardizing what constitutes a basic derivative variety. The markers of these and other markers are disclosed in the Soybase (funded by USDA Agricultural Research Service and Iowa State University) at 129.186.26.94 / SSR.html of the World Wide Web.

[0204] As used herein, the term "associated with..." refers to an identifiable and / or detectable relationship between two entities. For example, the phrase "associated with a modified flowering time" refers to a trait, locus, gene, allele, marker, phenotype, etc., or an expression product thereof, the presence or absence of which may affect or indicate that a plant or its offspring exhibits a range and / or degree of change in their flowering time and / or maturity value compared to a control plant. Thus, when a marker is linked to a trait and when the presence of a marker indicates whether and / or to what extent a desired trait or trait form will occur in a plant / germplasm comprising the marker, the marker is "associated" with the trait. Similarly, when a marker is linked to an allele and when the presence (or absence) of a marker indicates whether an allele exists (or does not exist) in a plant, germplasm, or population comprising the marker, the marker is "associated" with the allele. For example, a "marker associated with a novel E1 allele that confers a modified flowering time trait" refers to a marker whose presence or absence can be used to determine whether a novel E1 allele is present in a plant, and / or to what extent a plant will exhibit an altered flowering time compared to a control plant. Similarly, a "marker associated with a novel E1Lb allele that confers a modified flowering time trait" refers to a marker whose presence or absence can be used to determine whether a novel E1Lb allele is present in a plant, and / or to what extent a plant will exhibit an altered flowering time compared to a control plant.

[0205] The term "one or more alleles" refers to any of one or more alternative forms of a gene, all of which are involved in at least one trait or characteristic. In a diploid cell, the two alleles of a given gene occupy corresponding loci on a pair of homologous chromosomes.

[0206] The term "genotype" and its variants refer to the genetic composition of an organism, including, for example, whether a diploid organism is heterozygous (i.e., has two different alleles for a given gene or QTL) or homozygous (i.e., has the same allele for a given gene or QTL) for one or more genes or loci (e.g., SNPs, haplotypes, genetic mutations, insertions, or deletions).

[0207] In one embodiment, the marker used to identify plants comprising the alleles disclosed herein is a SNP. Non-limiting examples of SNP genotyping methods include hybridization, primer extension, oligonucleotide ligation, nuclease cleavage, minisequencing, and coded spheres. Such methods are well known and are disclosed in, for example, Gut, IG, Hum. Mutat. [Human Mutation] 17:475-492 (2001); Shi, Clin. Chem. [Clinical Chemistry] 47(2):164-172 (2001); Kwok, Pharmacogenomics [Pharmacogenomics] 1(1):95-100 (2000); and Bhattramakki and Rafalski, Discovery and application of single nucleotide polymorphism markers in plants [Plant GENOTYPING: THE DNA FINGERPRINTING OF PLANTS], CABI Publishing, Wallingford [Wallingford] (2001). A wide range of commercially available technologies utilize these and other methods to interrogate SNPs, including Masscode SupTM / Sup (Qiagen, Germantown, Maryland), ELISABASE™ (Hologic, Madison, Wisconsin), ELISABASE™ (Applied Biosystems, Foster City, California), ELISABASE™ (Applied Biosystems, Foster City, California), and Beadarrays SupTM / Sup (Illumina, San Diego, California).

[0208] In some embodiments, an assay (e.g., typically a two-step allele discrimination assay or similar assay), a KASPSupTM / Sup assay (typically a one-step allele discrimination assay or similar assay as defined below), or both may be used to identify SNPs associated with a modified flowering time trait. In an exemplary two-step assay, a forward primer, a reverse primer, and two assay probes that recognize two different alleles (or hybridization oligonucleotides) at the SNP site are employed. The forward and reverse primers are used to amplify a genetic locus containing a SNP associated with a modified FT trait. The specific nucleotide present at the SNP position is then assayed using the probe. In some embodiments, the assay probes and reaction conditions are designed so that the assay probe will hybridize only to the reverse complement of a 100% fully matched sequence, thereby allowing hybridization-based detection to identify which allele or alleles are present. In some embodiments, the probes are differentially labeled, for example with a fluorophore, so that two assay probes can be distinguished in a single reaction. Exemplary methods of amplification include employing the polymerase chain reaction (PCR) or the ligase chain reaction (LCR), using nucleic acid isolated from soybean plants or germplasm as a template in the PCR or LCR.

[0209] In some embodiments, many SNP alleles within or across linked sequences can be used together to describe the haplotype of any particular genotype. Ching et al., BMC Genet. [BMC Genetics] 3: 19 (2002) (page 14); Gupta et al., (2001) Curr Sci. [Contemporary Science] 80: 524-535, Rafalski, Plant Sci [Plant Science] 162: 329-333 (2002). In some cases, haplotypes can be more informative than single SNPs and can describe any particular genotype in more detail. For example, for a specific disease-resistant strain or variety, a single SNP can be allele "T", but allele "T" can also appear in a soybean breeding population for a recurrent parent. In this case, the combination of alleles of linked SNPs can be more informative. Once a unique haplotype is assigned to a donor chromosome region, the haplotype can be used in the population or any subpopulation thereof to determine whether an individual has a specific gene. The use of automated high-throughput marker detection platforms known to those of ordinary skill in the art makes this method efficient and effective.

[0210] These SNP markers can be used in marker-assisted breeding programs to transfer traits (such as natural traits or traits conferred by transgenics or traits conferred by genome editing) into a desired plant background. As used herein, the term "natural trait" refers to a trait that already exists in the germplasm, including wild relatives of the crop species, or a trait that can be generated by recombination of existing traits. For example, offspring plants from a cross between a donor soybean plant whose genome contains a nucleic acid sequence encoding an allele of SEQ ID NO: 5-14 and a recipient soybean plant that does not contain the nucleic acid sequence can be screened to detect the presence of a marker associated with a modified FT trait. Plants containing the marker can be selected and verified for the modified FT trait compared to control plants. In some embodiments, the marker comprises a primer sequence disclosed and described in Example 3.

[0211] IV. Plant Transformation

[0212] Once the gene editing cassette has been cloned into the expression system, it is transformed into a plant cell. The receptor and target expression cassette of the present invention can be introduced into a plant cell in a variety of technically recognized ways. In the case of a polynucleotide (e.g., a target nucleotide construct), the term "introduction" is intended to mean that the polynucleotide is presented to the plant in a manner that allows the polynucleotide to enter the interior of the plant cell. In the case of introducing more than one polynucleotide, these polynucleotides can be assembled as part of a single nucleotide construct, or assembled as a separate nucleotide construct, and can be located on the same or different transformation vectors. Therefore, these polynucleotides can be introduced into the target host cell in a single transformation event, in a separate transformation event, or, for example, in a plant as part of a breeding scheme. The method of the present invention does not rely on a specific method for introducing one or more polynucleotides into a plant, as long as the one or more polynucleotides are able to enter at least one cell of the plant. Methods for introducing polynucleotides into plants are known in the art, including but not limited to transient transformation methods, stable transformation methods, and virus-mediated methods.

[0213] "Transient transformation" in the context of a polynucleotide is intended to mean that the polynucleotide is introduced into a plant and not integrated into the genome of the plant.

[0214] "Stably introducing" or "stably introduced" in the context of a polynucleotide introduced into a plant means that the introduced polynucleotide is stably incorporated into the plant genome and thus the plant is stably transformed with the polynucleotide.

[0215] "Stable transformation" or "stably transformed" is intended to mean that the polynucleotide introduced into the plant (eg, a nucleotide construct described herein) is integrated into the genome of the plant and is capable of being inherited by its progeny, more particularly, by multiple successive generations of progeny.

[0216] A variety of transformation vectors that can be used for plant transformation are known to those of ordinary skill in the field of plant transformation, and the gene associated with the present invention can be used in combination with any such vector. The selection of the vector will depend on the preferred transformation technique and the target species for transformation. For some target species, different antibiotics or herbicide selectable markers may be preferred. Selectable markers routinely used in transformation include the nptll gene, which confers resistance to kanamycin and related antibiotics (Messing & Vierra Gene 19:259-268 (1982); Bevan et al., Nature 304:184-187 (1983)), the pat and bar genes, which confer resistance to the herbicide glufosinate (also known as phosphinothricin) (see White et al., Nucl. Acids Res 18:1062 (1990), Spencer et al. Theor. Appl. Genet 79:625-631 (1990) and U.S. Pat. Nos. 5,561,236 and 5,276,268), the hph gene, which confers resistance to the antibiotic hygromycin (Blochinger & Diggelmann, Mol. Cell. Res. 23:1064 (1990) and U.S. Pat. Nos. 5,561,236 and 5,276,268). Biol. 4:2929-2931), and the dhfr gene that confers resistance to methotrexate (Bourouis et al., EMBO J. 2(7):1099-1104 (1983)), the EPSPS gene that confers resistance to glyphosate (U.S. Pat. Nos. 4,940,935 and 5,188,642), the glyphosate N-acetyltransferase (GAT) gene that also confers resistance to glyphosate (Castle et al. (2004) Science 304:1151-1154; U.S. Patent Application Publication Nos. 20070004912, 20050246798 and 20050060767); and the mannose-6-phosphate isomerase gene that provides the ability to metabolize mannose (U.S. Pat. Nos. 5,767,378 and 5,994,629).

[0217] The method for plant regeneration is also well known in the art. For example, Ti plasmid vectors and direct DNA uptake, liposomes, electroporation, microinjection and microparticles have been utilized to deliver foreign DNA. In addition, bacteria from Agrobacterium can be utilized to transform plant cells. Below is the description of representative techniques for transforming both dicotyledons and monocotyledons together with representative plastid transformation techniques.

[0218] For transformation using Agrobacterium tumefaciens, many vectors are available. These typically carry at least one T-DNA border sequence and include vectors such as pBIN19 (Bevan, Nucl. Acids Res. (1984)). For construction of vectors useful in Agrobacterium transformation, see, e.g., U.S. Patent Application Publication No. 2006 / 0260011, which is incorporated herein by reference.

[0219] The transformation that does not use Agrobacterium tumefaciens avoids the need for T-DNA sequence in the transformation vector selected, and therefore except those carriers containing T-DNA sequence as described above, the carrier lacking these sequences can be utilized. The transformation technique that does not rely on Agrobacterium comprises the transformation via particle bombardment, protoplast uptake (for example PEG and electroporation) and microinjection. The selection of carrier depends on the preferred selection of transformed species to a great extent. For the structure of this type of carrier, referring to, for example U.S. Application No. 20060260011, which is incorporated herein by reference.

[0220] Transformation techniques for dicotyledons are well known in the art and include techniques based on Agrobacterium and techniques that do not require Agrobacterium. Non-Agrobacterium techniques involve the direct uptake of exogenous genetic material by protoplasts or cells. This can be accomplished by PEG or electroporation-mediated uptake, particle bombardment-mediated delivery or microinjection. Examples of these techniques are described below: Paszkowski et al., EMBO J. [European Molecular Biology Association Journal] 3: 2717-2722 (1984), Potrykus et al., Mol. Gen. Genet. [Molecular Genetics and General Genetics] 199: 169-177 (1985), Reich et al., Biotechnology [Biotechnology] 4: 1001-1004 (1986) and Klein et al., Nature [Natural] 327: 70-73 (1987). In each case, the transformed cells are regenerated into whole plants using standard techniques known in the art.

[0221] For the transformation of dicotyledons, Agrobacterium-mediated transformation is a preferred technique because of its high transformation efficiency and its wide applicability to many different species. Agrobacterium transformation typically involves transferring a binary vector (e.g., pCIB200 or pCIB2001) carrying the exogenous DNA of interest to an appropriate Agrobacterium strain, which can rely on the complement of the vir genes carried by the host Agrobacterium strain (e.g., CIB542 strain for pCIB200 and pCIB2001 (Uknes et al. Plant Cell 5:159-169 (1993))) or on a co-resident Ti plasmid or on a chromosome. The transfer of the recombinant binary vector to Agrobacterium is achieved by a three-parent hybridization method using an Escherichia coli strain carrying a recombinant binary vector and an auxiliary Escherichia coli strain carrying a plasmid (e.g., pRK2013) and capable of moving the recombinant binary vector into the target Agrobacterium strain. Alternatively, the recombinant binary vector can be transferred into Agrobacterium by DNA transformation (Hofgen and Willmitzer, Nucl. Acids Res. 16:9877 (1988)).

[0222] Transformation of a target plant species by recombinant Agrobacterium typically involves co-cultivation of the Agrobacterium with explants from the plant and follows protocols well known in the art. The transformed tissue is regenerated on selective medium carrying an antibiotic marker present between the binary plasmid T-DNA borders.

[0223] Another method of genetically transforming plant cells involves advancing inert or biologically active particles on plant tissues and cells. This technology is disclosed in U.S. Patents 4,945,050, 5,036,006 and 5,100,792 (all belonging to Sanford et al.). Generally, this method involves advancing inert or biologically active particles on cells under conditions that effectively penetrate the outer surface of the cell and provide for incorporation into the interior thereof. When inert particles are utilized, these particles can be coated with a vector containing the desired gene to introduce the vector into the cell. Alternatively, the target cell can be surrounded by a vector so that the vector is brought into the cell by the wake of the particles. Biologically active particles (e.g., dry yeast cells, dry bacteria or bacteriophages, each containing the DNA to be introduced) can also be advanced into plant cell tissues.

[0224] Transformation of most monocot species has now become a routine operation. Preferred techniques include using PEG or electroporation techniques to transfer genes directly into protoplasts, and particle bombardment into callus. Transformation can be performed with a single DNA species or multiple DNA species (i.e., co-transformation), and both techniques are suitable for use in the present invention. Co-transformation can have the following advantages: avoid complete vector construction and generate transgenic plants with non-sex-associated loci of the target gene and selectable marker, making it possible to remove the selectable marker in subsequent generations (if this is considered to be desired). However, a disadvantage of using co-transformation is the frequency of less than 100%, with which the isolated DNA species is integrated into the genome (Schocher et al. Biotechnology [biotechnology] 4: 1093-1096 (1986)).

[0225] Patent application EP 0 292 435, EP 0 392 225 and WO 93 / 07278 have described the technology for preparing callus and protoplasts from improved inbred strain maize, using PEG or electroporation to transform protoplasts and regenerating maize plants from the protoplasts transformed. People such as Gordon-Kamm (Plant Cell [plant cell] 2:603-618 (1990)) and Fromm (Biotechnology [biotechnology] 8:833-839 (1990)) have disclosed the technology for using particle bombardment to transform the maize strain that is derived from A188. In addition, people such as WO93 / 07278 and Koziel (Biotechnology [biotechnology] 11:194-200 (1993)) have described the technology for transforming improved inbred strain maize by particle bombardment. This technique utilizes immature maize embryos 1.5-2.5 mm long excised from maize ears 14-15 days after pollination and a PDS-1000 He Biolistics device for bombardment.

[0226] The use of Agrobacterium to transform monocotyledonous plants has also been described. See WO 94 / 00977 and U.S. Pat. No. 5,591,616, both of which are incorporated herein by reference. See also Negrotto et al., Plant Cell Reports 19:798-803 (2000), which is incorporated herein by reference.

[0227] The genetic traits engineered into the above-mentioned genome-edited or transgenic seeds and plants are transmitted through sexual reproduction or vegetative growth, and can thus be maintained and propagated in subsequent generations of plants. Typically, maintenance and propagation utilize known agricultural methods that are developed to suit specific purposes, such as tilling, sowing or harvesting.

[0228] The favorable genetic characteristics of genome editing or transgenic plants and seeds according to the present invention can be further utilized in plant breeding. Different breeding measures are taken according to the desired characteristics. Related technologies are well known in the art and include, but are not limited to, hybridization, inbreeding, backcross breeding, multi-line breeding, variety blending, interspecific hybridization, aneuploidy technology, etc. Therefore, the genome editing or transgenic seeds and plants according to the present invention can be used for breeding of improved plant strains (e.g., increasing the geographical range of cultivation).

[0229] Many suitable transformation methods using appropriate selectable markers (such as kanamycin), binary vectors (such as from Agrobacterium), and plant regeneration (such as from tobacco leaf discs) are well known in the art.

[0230] V. Establishing breeding zones based on altered flowering time characteristics.

[0231] Provided is a method for establishing where plants with genome editing at one or more of the E1 and E1Lb loci should be cultivated. In particular, the method can establish where soybean plants or their seeds should be grown, wherein the soybean plants have genome editing at one or both of the E1 and E1Lb loci, resulting in a novel allele combination different from the allele combination of a control plant containing alleles in wild-type form. The method requires determining a specific allele combination, and then comparing the flowering time of the changes produced by the specific allele combination. In an example embodiment, specifying a change in flowering time includes specifying a duration (such as hours, days, or weeks) of a change in flowering time (e.g., advance or delay) of the soybean plant relative to the control plant. For example, an allele combination that results in a flowering time of 50 days (e.g., a duration from VE to R1) compared to a control plant with a flowering time of 45 days specifies a change in flowering time (particularly, advance) of (50-45) 5 days or (5x 24) 120 hours. In some embodiments, a 5-day advance is associated with a defined relative maturity group transition. In other embodiments, a 10-day advance is associated with a defined relative maturity group shift. However, it will be appreciated that the relationship between the degree and direction of change in flowering time and the change in relative maturity group may not be linear and may be based on additional factors such as ambient weather conditions (e.g., temperature and humidity), cultivation location (indoors or outdoors), watering and chemical treatment frequency, etc.

[0232] As a first non-limiting example, a change in flowering time from a first time of about 90-100 days to a second time of about 87-97 days (e.g., 87 to 95 days) can be associated with a change in maturity group from RM 5.5 to RM 5.

[0233] As a second non-limiting example, a change in flowering time from a first time of about 90-100 days to a second time of about 83-84 days can be associated with a change in maturity group from RM 5.5 to RM 4.

[0234] As a third non-limiting example, a change in flowering time from a first time of about 90-100 days to a second time of about 70-72 days can be associated with a change in maturity group from RM 5.5 to RM 3.

[0235] As a fourth non-limiting example, a change in flowering time from a first time of about 90-100 days to a second time of about 58-62 days can be associated with a change in maturity group from RM 5.5 to RM 2.

[0236] As a fifth non-limiting example, a change in flowering time from a first time of about 90-100 days to a second time of about 43-44 days can be associated with a change in maturity group from RM 5.5 to RM 0 or RM 1.0.

[0237] As a sixth non-limiting example, a change in flowering time from a first time of about 90-100 days to a second time of about 37-41 days can be associated with a change in maturity group from RM 5.5 to RM 00.

[0238] As a seventh non-limiting example, a change in flowering time from a first time of about 90-100 days to a second time of about 30-31 days can be associated with a change in maturity group from RM 5.5 to RM 000.

[0239] In embodiments, the altered flowering time can be used to establish an altered maturity value or relative maturity group for the edited plant. Based on the change in flowering time, a geographic region (e.g., latitude, temperature region, etc.) can be selected. In embodiments, selecting a region can further include determining whether the plant is grown indoors (e.g., in a greenhouse) or outdoors (e.g., in a field).

[0240] As an example, based on the allele combination, a soybean plant can transition from growing in a first region to growing in a second region. As used herein, transitioning the growth of a plant from a first region to a second region means that the edited plant can additionally or optionally be grown in the second region, while the unedited control plant (from which the edited plant is derived or relative to which the flowering time change is measured) continues to grow only in the first region, and wherein the control plant cannot be grown in the second region.

[0241] As an example, based on the allele combination, the edited non-naturally occurring soybean plant can transition from growing in a first region between 40°N and 50°N (e.g., between 40°N and 45°N, or between 45°N and 50°N) to growing in a second region between 30°N and 40°N (e.g., between 30°N and 35°N, or between 35°N and 40°N) or between 20°N and 30°N (e.g., between 20°N and 25°N, or between 25°N and 30°N). As another example, based on the allele combination, the edited non-naturally occurring soybean plant can transition from growing in a first region between 30°N and 40°N (e.g., between 30°N and 35°N, or between 35°N and 40°N) to growing in a second region between 20°N and 30°N (e.g., between 20°N and 25°N, or between 25°N and 30°N). Here, the transition is from a region with longer days to a region with shorter days. In certain embodiments, the transition to a region with shorter days can be achieved due to an allele combination that increases the flowering time of the edited plants relative to control plants.

[0242] As an example, based on the allele combination, the edited non-naturally occurring soybean plant can transition from growing in a first region between 20°N and 30°N (e.g., between 20°N and 25°N, or between 25°N and 30°N) to growing in a second region between 30°N and 40°N (e.g., between 30°N and 35°N, or between 35°N and 40°N) or between 40°N and 50°N (e.g., between 40°N and 45°N, or between 45°N and 50°N). As another example, based on the allele combination, the edited non-naturally occurring soybean plant can transition from growing in a first region between 30°N and 40°N (e.g., between 30°N and 35°N, or between 35°N and 40°N) to growing in a second region between 40°N and 50°N (e.g., between 40°N and 45°N, or between 45°N and 50°N). Here, the transition is from a region with shorter days to a region with longer days. In certain embodiments, the transition to a region with longer days can be achieved due to an allele combination that reduces the flowering time of the edited plants relative to control plants.

[0243] An exemplary embodiment of a method for establishing where a soybean plant or its seeds should grow comprises: (a) introducing mutations at the E1 locus and the E1LB locus of the soybean plant genome via genomic modification using a site-directed nuclease; (b) selfing the plant for one or more generations to produce progeny plants that are homozygous at each of the E1 locus and the E1LB locus; (c) obtaining DNA from the progeny plant; (d) determining the allele combination of the progeny plant via a first assay of DNA indicating the type of mutation introduced at the E1 locus and a second assay of DNA indicating the type of mutation introduced at the E1LB locus; and (e) assigning a change in flowering time to the plant based on the determined allele combination, wherein the change in flowering time is relative to a control plant that does not contain the allele combination.

[0244] Another exemplary embodiment of the method includes editing at the E1 locus and the E1LB locus of the genome of a soybean plant via a site-directed nuclease; isolating DNA from edited offspring of the soybean plant; determining the allele combination of the edited offspring plant via a first DNA assay indicating the type of mutation introduced at the E1 locus and a second DNA assay indicating the type of mutation introduced at the E1LB locus; and specifying a change in flowering time of the offspring based on the determined allele combination, wherein the change in flowering time is relative to a control plant that does not contain the allele combination.

[0245] Additional embodiments of the method include editing the endogenous E1 gene and E1LB gene of the genome of a soybean plant; selfing the plant for one or more generations to produce offspring plants that are homozygous edited at each of the E1 gene and the E1LB gene; obtaining DNA from the offspring plant; determining the allele combination of the offspring plant via a first assay of DNA indicating the type of mutation introduced at the E1 gene and a second assay of DNA indicating the type of mutation introduced at the E1LB gene; and specifying a change in flowering time of the plant based on the determined allele combination, wherein the change in flowering time is relative to a control plant that does not contain the allele combination.

[0246] Another exemplary embodiment of a method for establishing where a soybean plant or its seeds should grow includes: a. introducing a mutation at the E1 locus and / or the E1LB locus of the soybean plant genome via genomic modification using a site-directed nuclease (e.g., introducing only in the E1 locus, only in the E1LB locus, or introducing in each of the E1 and E1LB loci); b. selfing the plant for one or more generations to produce a progeny plant that is homozygous for the mutation at the E1 locus and / or the E1LB locus; c. obtaining DNA from the progeny plant; d. determining the allele combination of the progeny plant via an assay indicating the mutation introduced at the E1 locus and / or the E1LB locus; and e. assigning a change in flowering time and / or maturity time to the progeny plant based on the determined allele combination, wherein the change in flowering time and / or maturity time is relative to a control plant that does not contain the determined allele combination. For example, a mutation is introduced at the nuclear localization signal (NLS) of the E1 locus and / or the E1LB locus. In a specific example, a mutation is introduced at the basic domain of the NLS of the E1 locus and / or the E1LB locus. In a specific example, a mutation is introduced at the second basic domain of the two basic domains of the nuclear localization signal (NLS) of the E1 locus and / or the E1LB locus, wherein the second basic domain is downstream relative to the first basic domain of the NLS. In an embodiment, the introduction includes transforming a plant cell with an expression cassette, the expression cassette comprising: (i) a nucleic acid encoding the site-directed nuclease; and (ii) a nucleic acid encoding at least one guide RNA (gRNA), the at least one guide RNA being directed to a target sequence at the E1 locus and / or the E1LB locus. In some examples, the at least one gRNA is directed to a target sequence comprising a second basic domain of a nuclear localization signal (NLS) at one of the E1 locus and the E1LB locus. In other examples, the at least one gRNA is directed to a target sequence comprising a second basic domain of a nuclear localization signal (NLS) at each of the E1 locus and the E1LB locus. In some examples, the nucleic acid encoding the site-directed nuclease is operably linked to a first promoter of the expression cassette, and the nucleic acid encoding the at least one gRNA is operably linked to a second promoter of the expression cassette, wherein the first promoter and the second promoter are different promoter sequences or have a common promoter sequence. In an embodiment, the expression cassette further comprises an enhancer operably linked to the first promoter or the second promoter, the enhancer being used to enhance transcription of the sequence operably linked to the promoter.As a non-limiting example, the site-directed nuclease is selected from the group consisting of: mega nuclease (MN), zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), Cas9 nuclease, Cfp1 nuclease, dCas9-Fok1, dCpf1-Fok1, chimeric Cas9-cytidine deaminase, chimeric Cas9-adenine deaminase, chimeric FEN1-Fok1, and Mega-TAL, nickase Cas9 (nCas9), chimeric dCas9 non-Fok1 nuclease, and dCpf1 non-Fok1 nuclease. In some examples, the mutation introduced into the E1 locus and / or the E1LB locus is selected from the group consisting of: allele substitution, one or more base insertions, one or more base deletions.

[0247] In a specific example, the allele combination includes one or more of the following: a mutant E1 allele that causes loss of E1 protein function; a mutant E1 allele that causes partial function of E1 protein; a mutant E1LB allele that causes loss of E1LB protein function; and a mutant E1LB allele that causes partial function of E1LB protein. For example, the mutant allele at the E1LB locus can correspond to any one of SEQ ID NOs: 15, 17, 19, 21, and 23; or encode a mutant E1LB protein corresponding to any one of SEQ ID NOs: 16, 18, 20, 22, and 24. In other examples, the mutant allele at the E1 locus corresponds to any one of SEQ ID NOs: 5, 7, 9, 11, and 13; or encodes a mutant E1 protein corresponding to any one of SEQ ID NOs: 6, 8, 10, 12, and 14.

[0248] In embodiments, the progeny plant has a modified flowering time and / or maturity time relative to a control plant, and wherein the control plant comprises a wild-type allele at each of the E1 locus and the E1LB locus. In some instances, specifying a change in the flowering time and / or maturity time comprises specifying a shortened number of days for the progeny plant's flowering time and / or maturity time relative to the control plant. In particular embodiments, specifying a change in the flowering time comprises a reduction in the number of days between the VE stage and the R1 stage of the progeny plant relative to the control plant, and / or wherein the change in the maturity time comprises a reduction in the number of days between the R1 stage and the R7 or R8 stage of the progeny plant relative to the control plant.

[0249] In an embodiment, introducing a mutation further comprises regenerating a transformed TO plant from the transformed plant cell, the transformed TO plant having a plurality of T1 seeds, wherein the plurality of T1 seeds contain a plurality of unique edits in the E1 locus and / or the E1LB locus; growing a plurality of T1 plants from the T1 seeds; and selfing the T1 plants for one or more generations to obtain progeny plants that are homozygous for the mutation introduced at the E1 locus and / or the E1LB locus. Wherein determining the allele combination comprises sequencing the E1 locus and the E1LB locus of the progeny plant; sequencing the E1 locus and the E1LB locus of the TO plant; and comparing the E1 locus and the E1LB locus sequences of the progeny plant with the corresponding sequences of the progeny plant to determine the mutation introduced into the E1 locus and / or the E1LB locus.

[0250] Non-limiting embodiments of the present invention include methods for establishing where a soybean plant or its seeds should grow. In an embodiment, the method includes: a. introducing mutations at the E1 locus and the E1LB locus of the soybean plant genome via genome modification using a site-directed nuclease; b. selfing the plant for one or more generations to produce a homozygous offspring plant at each of the E1 locus and the E1LB locus; c. obtaining DNA from the offspring plant; d. determining the allele combination of the offspring plant via a first determination of DNA indicating the type of mutation introduced at the E1 locus and a second determination of DNA indicating the type of mutation introduced at the E1LB locus; and e. specifying a change in the flowering time of the plant based on the determined allele combination, wherein the change in flowering time is relative to a control plant that does not contain the allele combination. In some embodiments, editing includes introducing mutations at the nuclear localization signal (NLS) at the E1 locus and the E1LB locus. In other embodiments, editing includes introducing mutations at the basic domain of the NLS at the E1 locus and the E1LB locus. In certain embodiments, the editing comprises introducing a mutation at the second basic domain of the two basic domains of the NLS at the E1 locus and the E1LB locus, wherein the second basic domain is downstream relative to the first basic domain of the NLS. In embodiments, specifying a change in flowering time comprises specifying a relative maturity group value relative to a control plant not comprising the allele combination, wherein optionally, the control plant comprises a wild-type allele at each of the E1 locus and the E1LB locus. In other embodiments, specifying a change in flowering time comprises specifying the number of days that the soybean plant is advanced or delayed in flowering time relative to the control plant.

[0251] Non-limiting embodiments of the present invention also include expression cassettes for editing plant cells. Example embodiments include transforming plant cells with an expression cassette, the expression cassette comprising (i) a nucleic acid encoding a site-directed nuclease; and (ii) a nucleic acid encoding at least one guide RNA (gRNA) for a target sequence. In an embodiment, the at least one gRNA is directed to a target sequence comprising a nuclear localization signal (NLS) at the E1 locus and the E1LB locus. In an embodiment, the at least one gRNA is directed to a target sequence comprising a second basic domain of a nuclear localization signal (NLS) at the E1 locus and the E1LB locus. In an embodiment, the nucleic acid encoding the site-directed nuclease is operably connected to a first promoter, and wherein the nucleic acid encoding the at least one gRNA is operably connected to a second promoter. In another embodiment of the expression cassette, an enhancer is operably connected to a first promoter or a second promoter. In an embodiment, the site-directed nuclease is selected from the group consisting of: a mega nuclease (MN), a zinc finger nuclease (ZFN), a transcription activator-like effector nuclease (TALEN), a Cas9 nuclease, a Cfp1 nuclease, a dCas9-Fok1, a dCpf1-Fok1, a chimeric Cas9-cytidine deaminase, a chimeric Cas9-adenine deaminase, a chimeric FEN1-Fok1, and Mega-TAL, a nickase Cas9 (nCas9), a chimeric dCas9 non-Fok1 nuclease, and a dCpf1 non-Fok1 nuclease.

[0252] Non-limiting embodiments of the present invention also include methods for editing plants at the E1 and / or E1Lb loci to produce novel alleles and plants having novel allele combinations, which confer altered flowering time characteristics to plants relative to control plants that do not contain the novel allele combinations. Example embodiments of the editing methods include introducing mutations into the E1 locus and the E1LB locus, the mutations selected from the group consisting of: allele substitution, one or more base insertions, one or more base deletions. In further embodiments, the method includes regenerating a transformed T0 plant from a transformed plant cell, the transformed T0 plant having a plurality of T1 seeds, wherein the plurality of T1 seeds contain a plurality of unique edits in the E1 locus and the E1LB locus; growing a plurality of T1 plants from the T1 seeds; and selfing the T1 plants for one or more generations to obtain offspring plants that are homozygous at the E1 locus and the E1LB locus.

[0253] Non-limiting embodiments of the present invention also include methods for determining novel allele combinations. In an exemplary embodiment, the method includes sequencing the E1 locus and the E1LB locus of the offspring plant; sequencing the E1 locus and the E1LB locus of the T0 plant; comparing the E1 locus and the E1LB locus sequences of the offspring plant with the corresponding sequences of the offspring plant to determine the type of mutation introduced into the E1 locus and the E1LB locus. Exemplary embodiments of allele combinations include loss-of-function E1 alleles or partially functional E1 alleles; and loss-of-function E1LB alleles or partially functional E1LB alleles. Still other combinations are possible.

[0254] Non-limiting embodiments of the present invention further include methods of producing soybean plants with modified flowering time. Example embodiments include introducing an edit into the E1 gene of a plant cell to produce a mutant E1 allele having reduced E1 protein function relative to the wild-type E1 allele; introducing another edit into the E1LB gene of the plant cell to produce a mutant E1LB allele having reduced E1LB protein function relative to the wild-type E1LB allele; regenerating an edited plant from the edited plant cell; and selfing the edited plant to obtain an edited offspring comprising an allele combination containing the mutant E1 allele and the mutant E1LB allele, wherein the edited offspring has a modified flowering time relative to the flowering time of a control plant comprising the wild-type E1 allele and / or the wild-type E1LB allele. In embodiments, introducing editing into the E1 gene comprises introducing multiple base pair deletions into the E1 gene, wherein the mutant E1 allele encodes a frameshifted E1 protein or a truncated E1 protein; and introducing editing into the E1LB gene comprises introducing multiple base pair deletions into the E1LB gene, wherein the mutant E1LB allele encodes a frameshifted E1LB protein or a truncated E1LB protein. In specific embodiments, the truncated E1 protein has no functional activity relative to the wild-type E1 protein, the in-frame deletion mutant E1 protein has partial functional activity relative to the wild-type E1 protein, the truncated E1LB protein has no functional activity relative to the wild-type E1LB protein, and wherein the in-frame deletion mutant E1LB protein has partial functional activity relative to the wild-type E1LB protein. In embodiments, introducing editing into the E1 gene comprises introducing editing into the basic domain of the nuclear localization signal of the E1 gene; and introducing editing into the E1LB gene comprises introducing editing into the basic domain of the nuclear localization signal of the E1LB gene. In an embodiment, introducing the edit into the E1 gene and the E1LB gene comprises transforming a plant cell with an expression cassette comprising: (i) a nucleic acid encoding a site-directed nuclease; (ii) a nucleic acid encoding at least one guide RNA (gRNA) for a target sequence; and (iii) at least one promoter operably linked to the site-directed nuclease. In an embodiment, the expression cassette further comprises another promoter operably linked to the at least one gRNA and an enhancer element optionally operably linked to the at least one promoter. In further embodiments, the at least one gRNA is directed to a target sequence comprising a nuclear localization signal (NLS) at the E1 locus and the E1LB locus.

[0255] Other example embodiments of methods of producing a soybean plant with a modified flowering time include introducing an edit into one or more of the E1 gene and the E1LB gene of a soybean plant cell to produce a mutant E1 allele and / or a mutant E1LB allele that has reduced function relative to the corresponding wild-type allele (e.g., producing only the mutant E1 allele while leaving the E1LB allele as wild-type, producing only the mutant E1LB allele while leaving the E1 allele as wild-type, or producing both mutant E1 and E1LB alleles each of the wild-type E1 genes); regenerating an edited plant from the edited plant cell; and selfing the edited plant to obtain an edited offspring plant comprising a non-naturally occurring allele combination, the non-naturally occurring allele combination comprising one or more of the mutant E1 allele and the mutant E1LB allele, wherein the edited offspring plant has a modified flowering time and / or maturity time relative to the flowering time and / or maturity time of a control plant comprising the wild-type E1 allele and the wild-type E1LB allele. In specific embodiments, introducing edits into the E1 gene comprises introducing multiple base pair deletions into the E1 gene, wherein the mutant E1 allele corresponds to any one of SEQ ID NOs: 5, 7, 9, 11, and 13, and encodes an in-frame deletion mutant E1 protein or a truncated E1 protein corresponding to any one of SEQ ID NOs: 6, 8, 10, 12, and 14. In other embodiments, the editing is introduced into the E1LB gene, including introducing multiple base pair deletions into the E1LB gene, wherein the mutant E1LB allele corresponds to any one of SEQ ID NOs: 15, 17, 19, 21, and 23, and encodes an in-frame deletion mutant E1LB protein or a truncated E1LB protein corresponding to any one of SEQ ID NOs: 16, 18, 20, 22, and 24. In these embodiments, the truncated E1 protein has no functional activity relative to the wild-type E1 protein, the in-frame deletion mutant E1 protein has partial functional activity relative to the wild-type E1 protein, the truncated E1LB protein has no functional activity relative to the wild-type E1LB protein, and the in-frame deletion mutant E1LB protein has partial functional activity relative to the wild-type E1LB protein. In an embodiment, the editing in the E1 gene is introduced into the second basic domain of the nuclear localization signal (NLS) of the E1 gene; and the editing of the E1LB gene is introduced into the second basic domain of the nuclear localization signal (NLS) of the E1LB gene.In an embodiment, introducing editing into the E1 gene and / or the E1LB gene comprises transforming a plant cell with an expression cassette comprising (i) a nucleic acid encoding a site-directed nuclease operably linked to a promoter, the promoter optionally further linked to an enhancer, the enhancer configured to enhance transcription of the site-directed nuclease by the promoter; and (ii) a nucleic acid encoding at least one guide RNA (gRNA) directed to a target sequence in the second basic domain of the NLS of the E1 gene and / or the E1LB gene.

[0256] In certain embodiments, the flowering time of the edited progeny plant is shorter than the flowering time of the control plant. In further embodiments, the relative maturity group value of the edited progeny plant is different from the relative maturity group value of the control plant.

[0257] Non-limiting embodiments of the present invention further include edited progeny plants produced by the methods disclosed above and additional progeny plants of the edited progeny plants, such as those obtained by breeding or selfing. In embodiments, the flowering time of the edited progeny plants is modified (e.g., shorter or longer) compared to the flowering time of the control plants. In embodiments, the relative maturity group value of the edited progeny plants is different from the relative maturity group value of the control plants.

[0258] Non-limiting embodiments of the present invention further include non-naturally occurring soybean plants having modified flowering time and comprising novel allele combinations. In embodiments, the novel allele combinations are selected from the group comprising: a mutant E1LB allele resulting in partial expression of the E1LB protein and a wild-type E1 allele; a mutant E1LB allele resulting in loss of expression of the E1LB protein and a wild-type E1 allele; a mutant E1LB allele resulting in partial expression of the E1LB protein and a mutant E1 allele resulting in partial expression of the E1 protein; a mutant E1LB allele resulting in loss of expression of the E1LB protein and a mutant E1 allele resulting in partial expression of the E1 protein; a mutant E1LB allele resulting in partial expression of the E1LB protein and a mutant E1 allele resulting in partial expression of the E1 protein; a mutant E1LB allele resulting in partial expression of the E1LB protein and a mutant E1 allele resulting in partial expression of the E1 protein; The invention relates to a non-natural soybean plant comprising a wild-type E1LB allele and a mutant E1 allele that causes a loss of expression of the E1 protein; and a mutant E1LB allele that causes a loss of expression of the E1LB protein and a mutant E1 allele that causes a loss of expression of the E1 protein, a wild-type E1LB allele and a mutant E1 allele that causes a loss of expression of the E1 protein, and a wild-type E1LB allele and a mutant E1LB allele that causes partial expression of the E1 protein, wherein the flowering time of the non-naturally occurring soybean plant is modified relative to a control plant comprising the wild-type E1 allele and the wild-type E1LB allele. In an embodiment, the mutant E1LB allele that causes partial expression or the mutant E1LB allele that causes a loss of expression is introduced by editing the E1LB gene of the plant using a DNA modification enzyme. In an embodiment, the mutant E1 allele that causes partial expression or the mutant E1 allele that causes a loss of expression is introduced by editing the E1 gene of the plant using a DNA modification enzyme.

[0259] Non-limiting embodiments of the present invention include modified soybean plants or plant parts thereof. In an embodiment, the modified soybean plant or plant part thereof comprises a non-naturally occurring mutant allele at the E1 locus and / or E1Lb locus, wherein the non-naturally occurring mutant allele is introduced via genome modification using a site-directed nuclease. In a specific embodiment, the non-naturally occurring mutant allele is a homozygous mutant allele. In an exemplary embodiment, the modified soybean plant or plant part thereof comprises a non-naturally occurring mutant allele at each of the E1 locus and the E1Lb locus, wherein the E1 locus and the E1Lb locus both comprise homozygous mutant alleles. In an embodiment, relative to unmodified wild-type E1 or E1LB gene alleles, the mutant allele exhibits a reduction in expression or enzymatic activity. In a specific embodiment, the mutant allele at the E1 locus or E1LB locus is included in a mutation in the second basic domain of the nuclear localization signal (NLS) of a protein encoded by a gene. In embodiments, the mutant alleles at the E1 locus and / or the E1LB locus comprise one or more mutation types selected from the group consisting of nonsense mutations, in-frame deletion mutations, missense mutations, frameshift mutations, splice site mutations, and any combination thereof.

[0260] In non-limiting embodiments of the modified soybean plant or plant part thereof, the mutant allele at the E1 locus results in one of: truncation of the E1 protein, non-functional E1 protein, reduced-function E1 protein, premature stop codon in the E1 gene, and in-frame deletion in the E1 gene; and wherein the mutant allele at the E1LB locus results in one of: truncation of the E1LB protein, non-functional E1LB protein, reduced-function E1LB protein, premature stop codon in the E1LB gene, and in-frame deletion in the E1LB gene. In specific embodiments of the modified soybean plant or plant part thereof, the modified plant has a shorter flowering time, such as fewer days between the VE stage and the R1 stage in the modified plant relative to the control plant, compared to a control plant comprising an unmodified wild-type E1 and / or wild-type E1LB gene allele. In additional or alternative embodiments, the modified plant has a shorter time to maturity compared to a control plant comprising an unmodified wild-type E1 and / or wild-type E1LB gene allele, such as fewer days between the R1 stage and the R7 or R8 stage in the modified plant relative to the control plant.

[0261] In specific embodiments of the modified soybean plant or plant part thereof, the homozygous mutant allele comprises a homozygous mutation at the E1 locus selected from the group consisting of: an 8 bp deletion from positions 147 to 154 of the E1 gene; a 13 bp deletion from positions 144 to 156 of the E1 gene; a 25 bp deletion from positions 131 to 155 of the E1 gene; a 9 bp deletion from positions 146 to 154 of the E1 gene; and a 15 bp substitution from positions 145 to 159 of the E1 gene, wherein the positions are with reference to the E1 gene of SEQ ID NO: 1. In embodiments, the homozygous mutation at the E1 locus corresponds to any one of SEQ ID NOs: 5, 7, 9, 11, and 13; or encodes a mutant E1 protein corresponding to any one of SEQ ID NOs: 6, 8, 10, 12, and 14.

[0262] In other embodiments of the modified soybean plant or plant part thereof, the homozygous mutant allele comprises a homozygous mutation at the E1LB locus selected from the group consisting of: a 7 bp deletion from positions 149 to 155 of the E1LB gene; a 3 bp deletion from positions 149 to 151 of the E1LB gene; a 139 bp deletion from positions 13 to 151 of the E1LB gene; a 6 bp deletion from positions 149 to 154 of the E1LB gene; and a 9 bp deletion from positions 148 to 156 of the E1LB gene, wherein the positions are with reference to the E1LB gene of SEQ ID NO: 3. In embodiments, the homozygous mutation at the E1LB locus corresponds to any one of SEQ ID NOs: 15, 17, 19, 21, and 23; or encodes a mutant E1LB protein corresponding to any one of SEQ ID NOs: 16, 18, 20, 22, and 24.

[0263] In other embodiments, the non-naturally occurring soybean plant with modified flowering time comprises an allele combination selected from the group consisting of: (a) a mutant E1LB allele that results in partial expression of the E1LB protein and a wild-type E1 allele; (b) a mutant E1LB allele that results in loss of expression of the E1LB protein and a wild-type E1 allele; (c) a mutant E1LB allele that results in partial expression of the E1LB protein and a mutant E1 allele that results in partial expression of the E1 protein; (d) a mutant E1LB allele that results in loss of expression of the E1LB protein and a mutant E1 allele that results in partial expression of the E1 protein; (e) (f) a mutant E1LB allele that causes a loss of expression of the E1LB protein and a mutant E1 allele that causes a loss of expression of the E1 protein; (g) a mutant E1 allele that causes a partial expression of the E1 protein and a wild-type E1LB allele; and (h) a mutant E1 allele that causes a loss of expression of the E1 protein and a wild-type E1LB allele; wherein the flowering time of the non-naturally occurring soybean plant is modified relative to a control plant comprising the wild-type E1 allele and the wild-type E1LB allele.

[0264] In specific embodiments, the mutant E1LB allele corresponds to any one of SEQ ID NOs: 15, 17, 19, 21, and 23; or encodes a mutant E1LB protein corresponding to any one of SEQ ID NOs: 16, 18, 20, 22, and 24; and the mutant E1 allele corresponds to any one of SEQ ID NOs: 5, 7, 9, 11, and 13; or encodes a mutant E1 protein corresponding to any one of SEQ ID NOs: 6, 8, 10, 12, and 14. In embodiments, the mutant E1LB allele resulting in partial expression or the mutant E1LB allele resulting in loss of expression is introduced by editing the E1LB gene of the plant using a DNA modification enzyme. In other embodiments, the mutant E1 allele resulting in partial expression or the mutant E1 allele resulting in loss of expression is introduced by editing the E1 gene of the plant using a DNA modification enzyme.

[0265] Non-limiting embodiments further include a breeding method comprising:

[0266] Crossing the non-naturally occurring soybean plant disclosed above with a different soybean plant that does not contain the allele combination of the non-naturally occurring soybean plant; and selecting progeny plants having modified flowering.

[0267] Examples

[0268] The following examples provide illustrative embodiments. Based on the present disclosure and the general level of skill in the art, it will be understood by those of ordinary skill that the following examples are intended to be illustrative only and that many changes, modifications and variations may be employed without departing from the scope of the subject matter of the present disclosure. Example 1: Modification of endogenous E1 and E1LB gene sequences in the genome of plant cells by delivering LbCas12a endonuclease and guide RNA expression cassettes

[0269] In one aspect of the invention, a method is provided for producing allelic variations of E1 and E1LB genes having altered expression levels and patterns relative to the endogenous form of the gene. In any plant species containing the E1 or E1LB gene, the allelic variations include allelic variants of the E1 and E1LB genes with reduced E1 or E1LB protein activity (also referred to herein as partial function variants) and allelic variants with lost E1 or E1LB protein activity (also referred to herein as loss-of-function variants). The method comprises using a DNA sequence of the second basic domain of the nuclear localization signal (NLS) of the protein encoded by the E1 and E1LB genes using a method that has been fully tested and described for plants. According to these recognized protocols, a guide RNA based on sequence homology in the same direction to a target region of the E1 and / or E1LB gene (e.g., the second basic domain of the NLS) that is targeted for alteration (e.g., targeted deletion of a functional region, insertion of a stop codon, insertion of a frameshift mutation, or any other alteration in genes and regulatory regions designed to affect gene expression) is synthesized, or the guide RNA is preferably encoded together with a gene encoding the LbCas12a protein in a vector for expression in a plant (but in some embodiments, LbCas12a can also be encoded in a separate vector).

[0270] The construction of LbCas12a expression vector and targeting donor has been described previously (H. Puchta et al., incorporated herein by reference in its entirety). Figure 2 ), Arabidopsis codon-optimized and catalytically inactive Lachnospiraceae Cas12a (hereinafter referred to as dLbCas12a, also referred to as dLbCpf1) is driven under the control of the Arabidopsis EF-1αA1 promoter with an eFMV enhancer, which is used to drive constitutive expression of Lb12Cas12a (prAtEF1aA1) (followed by the NOS terminator). A nuclear localization signal is also incorporated into the C-terminus of LbCas12a to improve its targeting to the nucleus.

[0271] like Figure 2As shown in A, a gRNA expression cassette comprising a soybean ubiquitin promoter (prGmUbi) operably linked at the 3' end to the coding sequence of the gRNA and the gRNA scaffold was synthesized by GenScript (www.genscript.com) and cloned into the binary vector 25462, which includes the aadA gene driven by the soybean EF promoter as a selection marker.

[0272] The design of guide RNA is well known to those skilled in the art. The target is GmE1 (SEQID NO: 1). Typically, guide RNA design is specific for each gene sequence and the desired change to be performed. For example, if only E1 or E1Lb sequence is required to be targeted, it is predicted to have the desired effect, such as reducing gene function. However, in this case, in view of the sequence homology of the GmE1Lb target of about 93%, the same gRNA is used for the target. If all members of the gene family are targeted, for example, if they have redundant functions, as in the case of E1 and E1Lb, the conserved sequences specific to these genes can be targeted to perform the desired changes. In this case, the target is the conserved second basic domain of the NLS of E1 and E1Lb.

[0273] The detailed information of binary vector 25462 is as follows:

[0274] bNLB insertion sequence 12,219 12,348 130 Left border of T-DNA of Agrobacterium tumefaciens nopaline ti plasmid in reverse

[0275] bNRB insertion sequence 4 143 140 Reverse T-DNA right border region of Agrobacterium tumefaciens nopaline ti plasmid

[0276] cLbCas12a CDS 1,871 5,743 3,873 Forward This LbCas12a is a codon-optimized version for Arabidopsis thaliana.

[0277] cRepA CDS14,471 15,544 1,074 Forward cRepA-01, where A changes to G at nt735

[0278] cSpec CDS12,628 13,416 789 Forward Also known as aadA; gene encoding the enzyme aminoglycoside 3' adenylyltransferase, conferring resistance to spectinomycin and streptomycin for use in maintaining vectors in E. coli and Agrobacterium.

[0279] cVirG CDS 13,716 14,441 726 Forward virG (putative) from pAD1289 (with TTG start codon). Described in Hansen et al. 1994, PNAS 91: 7603-7607

[0280] eFMV enhancer 157 698 542 Positive Fig Mosaic Virus (FMV) enhancer GmE1 target Uncharacterized 8,072 8,094 23 Positive

[0281] iAtEF1aA1u intron 1,252 1,864 613 Forward UTR intron of AtEF1aA1.

[0282] iGmEF intron 9,570 10,476 907 Forward The first intron of soybean elongation factor (EF) gene

[0283] iGmUbi1 intron 7,470 8,001 532 Forward 5'UTR intron of GmaSOYUBI gene.

[0284] oCOLE origin of replication 16,669 17,475 807 Reverse ColE1 origin of replication derived from pUC19 that functions in E. coli

[0285] oVS1 Origin of replication 15,587 15,991 405 Positive Origin of replication in Agrobacterium tumefaciens host

[0286] Complementary strand sequence in the first 6 bp of most Cpf1 crRNAs (LbCpf1, AsCpF1, and FnCpf1) to allow hammerhead self-cleavage at the correct position just before the subsequent crRNA

[0287] prAtEF1aA1 promoter 705 1,864 1,160 Forward Promoter from the Arabidopsis thaliana elongation factor EF-1αA1 gene

[0288] prGmEF promoter 8,424 10,487 2,064 forward

[0289] Translation elongation factor EF-1α / Tu promoter, including the first intron and adjacent UTR, from soybean (Williams 82)

[0290] prGmUbi1 promoter 6,004 8,001 1,998 Positive Ubiquitin 1 promoter candidate from soybean Williams 82

[0291] prVirG promoter 13,511 13,641 131 Forward virG promoter (Winans J. Bact. 172:2433-38 (1990)), which consists of two promoter elements, one responsive to acetosyringone and phosphate starvation (bp 45 to 83) and the other responsive to moderate acidification (bp 86 to 128)

[0292] rHDV unclassified RNA 8,095 8,162 68 Positive Sequence encoding a self-cleavable ribozyme from hepatitis delta virus (HDV).

[0293] rHH Unclassified RNA 8,014 8,050 37 Positive hammerhead RNA; conserved sequence motif from satellite RNA of some viruses (including tobacco ringspot virus) responsible for self-cleavage. Requires addition of a pairing sequence at the 5' end to ensure proper cleavage.

[0294] rHHLbCrRNA Unclassified RNA 8,008 8,050 43 Positive hammerhead RNA; conserved sequence motif from satellite RNA of some viruses (including tobacco ringspot virus) responsible for self-cleavage. Pairing sequence from Cas12a crRNA is added to the 5' end to ensure proper cleavage

[0295] rLbCrRNA-01 Unclassified RNA 8,051 8,071 21 Forward

[0296] The scaffold crRNA of LbCpf1 (currently called Cas12a), also known as the direct repeat (DR) of the guide RNA.

[0297] rLbgRNACas12aGmE1-01 Unclassified RNA 8,051 8,094 44 Forward

[0298] Cas12a (previously known as Cpf1) guide RNA, including the direct repeat sequence of LbCrRNA targeting ggacatcaaggagaagattctgc of GmE1

[0299] Start point not yet assigned to a feature 9,507 9,507 1 No transcription start site

[0300] Start point not yet assigned to a feature 9,507 9,507 1 No transcription start site

[0301] TATA BOX TATA_SIGNAL 1,166 1,176 11 Forward

[0302] <nobr>TATA box of AtEF1aA1 promoter

[0303] tNOS terminator 8,163 8,415 253 Forward synthesis of nopaline synthase terminator

[0304] tNOS terminator 5,751 6,003 253 Forward synthesis of nopaline synthase terminator

[0305] tPsE9 terminator 11,551 12,193 643 Forward 3'-UTR of pea (Pisum sativum) ribulose-1,5-bisphosphate carboxylase (rbcS2) small subunit E9

[0306] TSS unclassified features 7,346 7,346 1 No transcription start site

[0307] u5GmEF-01 5'UTR 9,507 9,569 63 Positive 5'UTR of soybean elongation factor (EF) gene, located before the intron

[0308] u5GmEF-02 5'UTR 10,477 10,487 11 Forward 5'UTR of soybean elongation factor (EF) gene

[0309] uAtL-EF1aA1 5'UTR 1,197 1,251 55 Forward 5'-UTR of AtEF1aA1 (Arabidopsis elongation factor-1α), leader sequence of AtEF1aA1 gene

[0310] uAtRNA ligase-01 3'UTR 705 959 255 Forward 3'UTR of Arabidopsis thaliana RNL (RNA ligase)

[0311] xAtCTP2-01 transit peptide 10,492 10,719 228 Positive Chloroplast transit peptide of Arabidopsis thaliana 3-phosphoshikimate 1-carboxyvinyltransferase / 5-enolpyruvylshikimate-3-phosphate / EPSP synthase (AT2G45300)

[0312] x Linker-08 Unclassified Features 1,895 1,984 90 Forward Peptide Linker based on GGGGS unit which is repeated 6 times to produce a 30aa protein linker which is soybean codon optimized

[0313] xSGGS linker-05 Unclassified features 5,696 5,707 12 Forward 4aa linker for fusion proteins from the paper: Nature Biotechnology, Vol. 35, pp. 438-440 (2017), which is soybean codon-optimized

[0314] xSGGS linker-06 Unclassified features 5,708 5,719 12 Forward 4aa linker of fusion protein from the paper: Nature Biotechnology, Vol. 35, pp. 438-440 (2017), which is soybean codon optimized

[0315] xSV40NLS-13 Unassigned features 5,675 5,695 21 Positive 7aa nuclear localization signal from SV40. It is soybean codon optimized

[0316] xSV40NLS-13 Unassigned features 1,874 1,894 21 Positive 7aa nuclear localization signal from SV40. It is soybean codon optimized

[0317] xSV40NLS-14 Unassigned features 5,720 5,740 21 Positive 7aa nuclear localization signal from SV40, which is soybean codon optimized.

[0318] (a) gRNA design

[0319] One gRNA was designed to target the second basic domain of NLS at both genes E1 and E1Lb, such as Figure 3A The target sequence of gRNA is based on the consensus sequence determined after alignment of the conserved domains ( Figure 3B ). The gRNA sequence is (SEQ ID NO: 37): TTTAGGACATCAAGGAGAAGATTCTGC (PAM: TTTA)

[0320] (b) Novel alleles of E1 and E1Lb

[0321] The novel alleles of E1 and E1Lb generated using gene editing include in-frame deletion mutations in the second basic NLS domain of the target gene. Such in-frame deletions are integer multiples of 3bp and include, for example, deletions of 6bp, 9bp, 12bp, and 15bp, and result in weak alleles with reduced expression levels relative to their wild-type counterparts. The mutant protein encoded by the in-frame deletion mutation is shorter than the wild-type protein and has reduced activity. Example in-frame deletion alleles and their arrangement relative to the second basic NLS domain of the target gene are shown in Figure 6 (Alignment is shown at the nucleotide and amino acid level). In some embodiments, the in-frame deletion results in a leaky allele and has reduced E1 or E1Lb activity relative to the wild-type counterpart. In other embodiments, the in-frame deletion results in an inactive allele.

[0322] The novel alleles of E1 and E1Lb generated using gene editing also include loss-of-function (LOF) deletion mutations in the second basic NLS domain of the target gene. Such lof deletions include, for example, deletions of 4 bp, 7 bp, and 8 bp (i.e., not an integer multiple of 3 bp). Example lof deletion alleles and their arrangement relative to the second basic NLS domain of the target gene are shown in Figure 7 In some embodiments, the alignment can be shown at the nucleotide and amino acid levels. Figure 6 and Figure 7 Comparison with Figure 3A The alignments were compared to determine the location of the mutation.

[0323] Example 2: Soybean transformation method

[0324] Soybean (Soybean, Jack variety) seeds were sterilized by chlorine gas and imbibed in germination medium at 25°C in the dark. Explants were prepared using imbibed seeds by trimming the hypocotyl, removing one cotyledon and leaf primordium as described by Khan et al. (Method of transforming soybean, WIPO International Publication No. WO2004000006, December 31, 2003; incorporated by reference) and Watts J. et al. (U.S. Pat. No. 9,758,792, incorporated by reference). The shoot apex region and the cotyledon node region were further gently wounded with the tip of a scalpel blade. The prepared explants were immediately infected with an Agrobacterium suspension containing the EHA101 Agrobacterium tumefaciens strain containing the binary vector 25462. At least 2 hours after inoculation, the explants were placed on co-cultivation medium at 23°C in the dark for 5 days.

[0325] After the co-cultivation, preferably explant is transferred to the recovery medium without selection agent, at 24 ℃, under 16 hours illumination / 8 hours dark scheme, continues about 7 days.The explant with cotyledon that will be recovered is transferred to the regeneration medium (selecting together with glyphosate) and continues about 3 weeks.The explant with a plurality of bud clusters that will be developed is transferred to the elongation medium (selecting together with glyphosate) and is used for bud elongation.Per 3 weeks, carry out to the subculture in the fresh elongation medium, until the bud of elongation is long enough (>3cm) to take samples for molecular analysis.

[0326] Example 3: Molecular Analysis

[0327] Before the E0 plants from the transformation were sent to the greenhouse, DNA extracted from the leaves of the E0 plants and the 06KG wild type (used as a control) were used as templates to identify the T-DNA insertion copy number by Taqman assay, and target gene editing was identified by Singer sequencing. The edited events with single-copy T-DNA insertions were sent to the greenhouse to harvest E1 seeds. The 06KG background has relative maturity groups of genotypes E1E2E3E4 and 5.5.

[0328] (a) Specific amplification of target genes (E1 and E1Lb)

[0329] Two pairs of primers specific for E1 and E1Lb were designed for gene cloning. The lengths of the DNA fragments amplified by PCR were 1668 bp (E1) and 1647 bp (E1Lb), respectively. The PCR specific primers used are listed in Table 1 below. The PCR reaction and cycle details are provided in Table 2 and Table 3, respectively.

[0330] Table 1: PCR-specific primers for E1 and E1Lb

[0331] Forward primer (SEQ ID NO: 25) E1 GTTATCATGCTTGAAAATGATGATG Reverse primer (SEQ ID NO: 26) E1 GTGCATAGATCTCATGCTAGACCT Forward primer (SEQ ID NO: 27) E1 TCCATTGTTTGTAGCGCATGGTC Reverse primer (SEQ ID NO: 28) E1 CATAGATCTCCTGCTAGCTAGACC

[0332] Table 2: PCR reaction mixture for E1 and E1Lb gene amplification

[0333]

[0334] Table 3: PCR Cycling Conditions for E1 and E1Lb

[0335]

[0336] (b) Target gene sequencing:

[0337] To determine the mutation type at the target site, E1 and E1Lb specific amplified fragments were used to analyze the target site sequence. The PCR products were detected by 1% agarose gel electrophoresis and then sequenced. The E1 and E1Lb gene sequencing primers are shown in Table 4.

[0338] Table 4: Sequencing primers for E1 and E1Lb

[0339] Sequencing primer (SEQ ID NO: 30) E1 GCTAGTAGTGTAAACACTCAAAACAC Sequencing primer (SEQ ID NO: 29) E1 TGCCTTTCTACTGGCTATGAC

[0340] (c) TAQMAN assay

[0341] The T-DNA insertion copy number was identified by Taqman assay. Specific primers for target gene (Cas12a) and internal housekeeping gene (Adh) amplification are shown in Table 5, and probe sequences are shown in Table 6.

[0342] Table 5: PCR specific primers for Cas12a and Adh used in Taqman assay

[0343]

[0344]

[0345] Table 6: Probes used in Taqman assays

[0346]

[0347] Example 4: Event selection for phenotyping

[0348] Mutations are identified by sequence peaks. Heterozygous mutations show a chaotic peak after the target site, while wild-type and homozygous mutations show a single peak at the target. The sequence of the homozygous mutation is compared with the wild-type to further determine the variation of the target ( Figure 4A-4B and Figure 5A-Figure 5B ).

[0349] (a)E1 generation

[0350] After propagation and segregation, homozygous mutations of five different genotypes (representing five different combinations of E1 and E1Lb) were obtained in the E1 generation. When grown in a greenhouse under 16 h day length conditions with a sowing date of July (summer sowing), these edited events had various shortened flowering times. The phenotypes of E1 generation soybean plants containing the novel allele combinations are shown in Figure 8 The changes in flowering time of E1 generation plants caused by the novel allele combination are shown in Table 7 below.

[0351] Table 7: Details of homozygous mutants in the E1 generation (abbreviations used: Lof - loss of function, In-frame - in-frame deletion in the NLS and Partial function)

[0352]

[0353]

[0354] (b) E2 generation

[0355] After two generations of propagation and segregation, in the E2 generation, 9 different genotypes (representing 8 different E1 and E1Lb allele combinations) of homozygous mutations without T-DNA were obtained and compared with the wild-type allele combination genotype. The phenotypes of the E2 generation soybean plants containing the novel allele combination are shown in Figure 9-11 Detailed information for some example mutants is shown in Table 8.

[0356] We were able to successfully obtain edited 06KG events with various shortened flowering times. The edits were homozygous mutations and there was no Cas12a editing. When grown in a greenhouse with a sowing date of February (winter sowing) under 16h day length conditions, these edited events had various shortened flowering times

[0357] The changes in flowering time of E2 plants caused by the new allele combination are shown in Fig.12 middle.

[0358] Table 8: Details of homozygous mutants without T-DNA (abbreviations used: Lof - loss of function)

[0359]

[0360]

[0361] Example 5: Phenotyping in the greenhouse

[0362] (a) Plant materials, growth conditions and phenotyping

[0363] Soybean wild type 06KG (MG5.5) and edited 06KG events were grown in a greenhouse (Beijing) with a sowing date of February (i.e., winter). The environment in the winter greenhouse was set to a day temperature of 28°C and a night temperature of 18°C. Sodium lamps were used to supply light from 5am to 9pm. The average photon flux was 300umol / m 2 / s. Plants were grown under long day (LD) conditions (16 h light / 8 h dark cycle). Flowering time was recorded as days after emergence (DAE) when the first flower opened (R1 stage).

[0364] (b) Phenotyping data of different E1 and E1Lb allele combinations under greenhouse conditions

[0365] The results of phenotyping various non-naturally occurring soybean plants having exemplary allele combinations are shown in Tables 9 and Fig.12 middle.

[0366] Table 9: Phenotyping data of different combinations of E1 and E1Lb alleles under greenhouse conditions (abbreviations used: Lof - loss of function; In-frame - deletion in NLS; FT - flowering time)

[0367]

[0368]

[0369] Example 6: Non-naturally occurring soybean plants comprising novel combinations of alleles that confer altered flowering time and / or maturity characteristics to the plants.

[0370] Based on the phenotyping results ( Figure 8-Figure 11 ) and flowering time data ( Fig.12 , Tables 7 and 9), various conclusions were drawn on the roles of E1 and E1Lb genes and their novel alleles in soybean flowering development.

[0371] Plants containing a single E1 loss-of-function mutation result in significantly earlier flowering times. In an embodiment, the flowering time is 55 days earlier than its wild-type counterpart. Plants containing a single E1 loss-of-function mutation also have changes in plant architecture that dwarf the plants, which may be due to early termination of stem growth.

[0372] In the background of E1 loss-of-function genotype, E1Lb mutations appear to have additive effects on early flowering time and termination of stem growth, with the E1Lb lof allele having a larger effect than the E1Lb in-frame allele (e.g., in Figure 8-Figure 12 In the assay, plants with a wild-type (WT) allele background were compared to those with the E1 / E1Lb genotypes of lof:lof, lof:in-frame, and lof:WT).

[0373] Plants containing a single E1 in-frame deletion mutation appear to promote an earlier flowering time, but not as significantly earlier as the E1 lof mutation. In an embodiment, the flowering time of a single E1 in-frame deletion mutation is 15 days earlier than its wild-type counterpart. Plants containing a single E1 in-frame deletion mutation appear to have no changes in plant architecture.

[0374] In the E1 in-frame deletion mutant genotype background, the E1Lb mutation appears to have an additive effect on early flowering time and termination of stem growth, with the E1Lb lof allele having a larger effect than the E1Lb in-frame allele (e.g., in Figure 8-Figure 12 In the assay, plants with a wild-type (WT) allele background were compared to those with the E1 / E1Lb genotypes of in-frame:in-frame, in-frame:lof, and in-frame:WT).

[0375] Plants containing a single E1Lb loss-of-function mutation showed a slight increase in early flowering (in the example, 7-8 days earlier) with no observable effect on plant architecture. Plants containing a single E1Lb in-frame deletion mutation showed a slight increase in early flowering (in the example, 7-8 days earlier) with no observable effect on plant architecture. In the E1 WT genotype background, both the E1Lb loss-of-function allele and the E1Lb in-frame deletion allele had similar effects on flowering (e.g., Figure 8-Figure 12 In the assay, plants with a wild-type (WT) allele background were compared to those with the E1 / E1Lb genotypes of WT:inframe and WT:lof).

[0376] Sequence Listing

[0377]

[0378]

[0379] SEQ ID NO: 1 (E1 CDS sequence; WT):

[0380] ATGAGTTTACAATCTCAAAGCCCATCAAAGTTCACGACCCTATTC

[0381] ATCTCTTCCAACATGAGCAACCCTTCAGATGAAAGGGAGCAGTGT

[0382] CAAAAGAAGAGGAAATCCACCATATGCGAAGCCTCTAACTTTAGG

[0383] ACATCAAGGAGAAGATTCTGCAGCAACAACAAAAATGAAGAGGA

[0384] GATGAACAATAAGGGAGTTTCAACAACACTGAAGCTTTTACGATGA

[0385] TCCTTGGAAGATCAAGAAGACGCTAACCGATAGCGATTTGGGAAT

[0386] CCTAAGTAGACTCTTGCTGGCTGCAGATTTGGTGAAGAAACAAATTTTGCCTATGTTGGGTGCATATCATGCAAGAGCTGCAGAAACTGAAGGGACCCCAGTTAGAGTTTGGGACATGGACACCAAATCCATGCACCAACTCGTTCTAAAGCGATG GTCTTCATCCAAGAGCTATGTTCTTATTGGAAAGTGGAACCAAGATTTCGTCAGAAGAAGAGATCTCAGGAAAGGTGATGAGATCGGATTTCATTGGGATCCATATAATTGCGTTTTCAATTTCTGTGTCCTTAAACAAGCTATGCCAGAGAATTAA

[0387] SEQ ID NO:2 (Amino acid sequence of E1; WT):

[0388] MSLQSQSPSKFTTLFISSNMSNPSDEREQCQKKRKSTICEASNFRTSRRRFCSNNKNEEEMNNKGVSTTLKLYDDPWKIKKTLTDSDLGILSRLLLAADLVKKQILPMLGAYHARAAETEGTPVRVWDMDTKSMHQLVLKRWSSSKSYVLIGKWNQDFVRRRDLRKGDEIGFHWDPYNCVFNFCVLKQAMPEN

[0389] SEQ ID NO:3 (CDS sequence of E1Lb; WT):

[0390] ATGAGTTTACAATCACAAATCCCATCAAAGTTTAAAATAATATTCATCTCTTCCAACATGAGCAATCATTCAGATGAGAAGGAGCAGTGTCAAAAGAAGAGGAAATCCACCATATGTGAAGCCTCCAACTTTAGGACATCAAGGAGAAGATTCTGCAGCAACAAAAATGAAGAGGAGATGAACAAGGGAGTTTCAACAACACTGAAGCTTTATGATGACCCTTGGAAGATCAAGAAGACGCTAACCGATAGCGATTTGGGAATCCTAAGTAGACTCTCGCTGGCTACAGATTTGGTGAAGAAGCAAATTTTGCCTATGTTGGGTGCAGATCATGCAAGAGCTGCAGAAACTGAAGAAGGGACCCCAGTTAGAGTTTGGGACATGGACACCAAATCCATGCACCAGCTCGTTCTAAAGCGATGGTCTTCTTCCAAGAGCTATGTTCTTATTGCAAAGTGGAACCAAGATTTCGTGAGAAGAAGAGACCTCAAGAAAGGGGATGAGATCGGATTTCATTGGGATCCATATAATTGCGTTTTCAATTTCTGTGTCCTTAAACGAGCTATGCCAGAGAATTAA

[0391] SEQ ID NO:4 (Amino acid sequence of E1Lb; WT):

[0392] MSLQSQIPSKFKIIFISSNMSNHSDEKEQCQKKRKSTICEASNFRTSRRRFCSNKNEEEMNKGVSTTLKLYDDPWKIKKTLTDSDLGILSRLSLATDLVKKQILPMLGADHARAAETEEGTPVRVWDMDTKSMHQLVLKRWSSSKSYVLIAKWNQDFVRRRDLKKGDEIGFHWDPYNCVFNFCVLKRAMPEN

[0393] SEQ ID NO:5 (E1 - D8 CDS sequence; Lof):

[0394] ATGAGTTTACAATCTCAAAGCCCATCAAAGTTCACGACCCTATTC

[0395] ATCTCTTCCAACATGAGCAACCCTTCAGATGAAAGGGAGCAGTGT

[0396] CAAAAGAAGAGGAAATCCACCATATGCGAAGCCTCTAACTTTAGG

[0397] ACATCAAGGAGGCAGCAACAACAAAAATGAAGAGGAGATGAACA

[0398] ATAAGGGAGTTTCAACAACACTGAAGCTTTACGATGATCCTTGGA

[0399] AGATCAAGAAGACGCTAACCGATAGCGATTTGGGAATCCTAAGTA

[0400] GACTCTTGCTGGCTGCAGATTTGGTGAAGAAACAAATTTTGCCTA

[0401] TGTTGGGTGCATATCATGCAAGAGCTGCAGAAACTGAAGGGACC

[0402] CCAGTTAGAGTTTGGGACATGGACACCAAATCCATGCACCAACTC

[0403] GTTCTAAAGCGATGGTCTTCATCCAAGAGCTATGTTCTTATTGGA

[0404] AAGTGGAACCAAGATTTCGTCAGAAGAAGAGATCTCAGGAAAGG

[0405] TGATGAGATCGGATTTCATTGGGATCCATATAATTGCGTTTTCAA

[0406] TTTCTGTGTCCTTAAACAAGCTATGCCAGAGAATTAA

[0407] SEQ ID NO:6 (Amino acid sequence of E1-D8; Lof):

[0408] MSLQSQSPSKFTTLFISSNMSNPSDEREQCQKKRKSTICEASNFRTSR

[0409] RQQQQK

[0410] SEQ ID NO:7 (CDS sequence of E1-D13; Lof):

[0411] ATGAGTTTACAATCTCAAAGCCCATCAAAGTTCACGACCCTATTC

[0412] ATCTCTTCCAACATGAGCAACCCTTCAGATGAAAGGGAGCAGTGT

[0413] CAAAAGAAGAGGAAATCCACCATATGCGAAGCCTCTAACTTTAGG

[0414] ACATCAAGAGCAACAACAAAAATGAAGAGGAGATGAACAATAAG

[0415] GGAGTTTCAACAACACTGAAGCTTTACGATGATCCTTGGAAGATC

[0416] AAGAAGACGCTAACCGATAGCGATTTGGGAATCCTAAGTAGACTC

[0417] TTGCTGGCTGCAGATTTGGTGAAGAAACAAATTTTGCCTATGTTG

[0418] GGTGCATATCATGCAAGAGCTGCAGAAACTGAAGGGACCCCAGT

[0419] TAGAGTTTGGGACATGGACACCAAATCCATGCACCAACTCGTTCT

[0420] AAAGCGATGGTCTTCATCCAAGAGCTATGTTCTTATTGGAAAGTG

[0421] GAACCAAGATTTCGTCAGAAGAAGAGATCTCAGGAAAGGTGATG

[0422] AGATCGGATTTCATTGGGATCCATATAATTGCGTTTTCAATTTCT

[0423] GTGTCCTTAAACAAGCTATGCCAGAGAATTAA

[0424] SEQ ID NO:8 (Amino acid sequence of E1-D13; Lof):

[0425] MSLQSQSPSKFTTLFISSNMSNPSDEREQCQKKRKSTICEASNFRTSR

[0426] ATTKMKRR

[0427] SEQ ID NO:9 (CDS sequence of E1-D25; Lof):

[0428] ATGAGTTTACAATCTCAAAGCCCATCAAAGTTCACGACCCTATTC

[0429] ATCTCTTCCAACATGAGCAACCCTTCAGATGAAAGGGAGCAGTGT

[0430] CAAAAGAAGAGGAAATCCACCATATGCGAAGCCTCTAACTCAGCA

[0431] ACAACAAAAATGAAGAGGAGATGAACAATAAGGGAGTTTCAACA

[0432] ACACTGAAGCTTTACGATGATCCTTGGAAGATCAAGAAGACGCTA

[0433] ACCGATAGCGATTTGGGAATCCTAAGTAGACTCTTGCTGGCTGCA

[0434] GATTTGGTGAAGAAACAAATTTTGCCTATGTTGGGTGCATATCAT

[0435] GCAAGAGCTGCAGAAACTGAAGGGACCCCAGTTAGAGTTTGGGA

[0436] CATGGACACCAAATCCATGCACCAACTCGTTCTAAAGCGATGGTC

[0437] TTCATCCAAGAGCTATGTTCTTATTGGAAAGTGGAACCAAGATTT

[0438] CGTCAGAAGAAGAGATCTCAGGAAAGGTGATGAGATCGGATTTC

[0439] ATTGGGATCCATATAATTGCGTTTTCAATTTCTGTGTCCTTAAACA

[0440] AGCTATGCCAGAGAATTAA

[0441] SEQ ID NO:10 (Amino acid sequence of E1-D25; Lof):

[0442] MSLQSQSPSKFTTLFISSNMSNPSDEREQCQKKRKSTICEASNSATTK

[0443] MKRR

[0444] SEQ ID NO:11 (CDS sequence of E1-D9; Lof):

[0445] ATGAGTTTACAATCTCAAAGCCCATCAAAGTTCACGACCCTATTC

[0446] ATCTCTTCCAACATGAGCAACCCTTCAGATGAAAGGGAGCAGTGT

[0447] CAAAAGAAGAGGAAATCCACCATATGCGAAGCCTCTAACTTTAGG

[0448] ACATCAAGGAGCAGCAACAACAAAAATGAAGAGGAGATGAACAA

[0449] TAAGGGAGTTTCAACAACACTGAAGCTTTACGATGATCCTTGGAA

[0450] GATCAAGAAGACGCTAACCGATAGCGATTTGGGAATCCTAAGTA

[0451] GACTCTTGCTGGCTGCAGATTTGGTGAAGAAACAAATTTTGCCTA

[0452] TGTTGGGTGCATATCATGCAAGAGCTGCAGAAACTGAAGGGACC

[0453] CCAGTTAGAGTTTGGGACATGGACACCAAATCCATGCACCAACTC

[0454] GTTCTAAAGCGATGGTCTTCATCCAAGAGCTATGTTCTTATTGGA

[0455] AAGTGGAACCAAGATTTCGTCAGAAGAAGAGATCTCAGGAAAGGTGATGAGATCGGATTTCATTGGGATCCATATAATTGCGTTTTCAATTTCTGTGTCCTTAAACAAGCTATGCCAGAGAATTAA

[0456] SEQ ID NO:12 (Amino acid sequence of E1 - D9; Lof):

[0457] MSLQSQSPSKFTTLFISSNMSNPSDEREQCQKKRKSTICEASNFRTSRSSNNKNEEEMNNKGVSTTLKLYDDPWKIKKTLTDSDLGILSRLLLAADLVKKQILPMLGAYHARAAETEGTPVRVWDMDTKSMHQLVLKRWSSSKSYVLIGKWNQDFVRRRDLRKGDEIGFHWDPYNCVFNFCVLKQAMPEN

[0458] SEQ ID NO:13 (CDS sequence of E1 - S15; Lof):

[0459] ATGAGTTTACAATCTCAAAGCCCATCAAAGTTCACGACCCTATTCATCTCTTCCAACATGAGCAACCCTTCAGATGAAAGGGAGCAGTGTCAAAAGAAGAGGAAATCCACCATATGCGAAGCCTCTAACTTTAGGACATCAAGGAGTTTCAACAACATGAACAACAAAAATGAAGAGGAGATGAACAATAAGGGAGTTTCAACAACACTGAAGCTTTACGATGATCCTTGGAAGATCAAGAAGACGCTAACCGATAGCGATTTGGGAATCCTAAGTAGACTCTTGCTGGCTGCAGATTTGGTGAAGAAACAAATTTTGCCTATGTTGGGTGCATATCATGCAAGAGCTGCAGAAACTGAAGGGACCCCAGTTAGAGTTTGGGACATGGACACCAAATCCATGCACCAACTCGTTCTAAAGCGATGGTCTTCATCCAAGAGCTATGTTCTTATTGGAAAGTGGAACCAAGATTTCGTCAGAAGAAGAGATCTCAGGAAAGGTGATGAGATCGGATTTCATTGGGATCCATATAATTGCGTTTTCAATTTCTGTGTCCTTAAACAAGCTATGCCAGAGAATTAA

[0460] SEQ ID NO:14 (Amino acid sequence of E1-S15; Lof):

[0461] MSLQSQSPSKFTTLFISSNMSNPSDEREQCQKKRKSTICEASNFRTSRSFNNMNNKNEEEMNNKGVSTTLKLYDDPWKIKKTLTDSDLGILSRLLLAADLVKKQILPMLGAYHARAAETEGTPVRVWDMDTKSMHQLVLKRWSSSKSYVLIGKWNQDFVRRRDLRKGDEIGFHWDPYNCVFNFCVLKQAMPEN

[0462] SEQ ID NO:15 (E1LB-D7 CDS sequence; Lof):

[0463] ATGAGTTTACAATCACAAATCCCATCAAAGTTTAAAATAATATTCATCTCTTCCAACATGAGCAATCATTCAGATGAGAAGGAGCAGTGTCAAAAGAAGAGGAAATCCACCATATGTGAAGCCTCCAACTTTAGGACATCAAGGAGAACAGCAACAAAAATGAAGAGGAGATGAACAAGGGAGTTTCAACAACACTGAAGCTTTATGATGACCCTTGGAAGATCAAGAAGACGCTAACCGATAGCGATTTGGGAATCCTAAGTAGACTCTCGCTGGCTACAGATTTGGTGAAGAAGCAAATTTTGCCTATGTTGGGTGCAGATCATGCAAGAGCTGCAGAAACTGAAGAAGGGACCCCAGTTAGAGTTTGGGACATGGACACCAAATCCATGCACCAGCTCGTTCTAAAGCGATGGTCTTCTTCCAAGAGCTATGTTCTTATTGCAAAGTGGAACCAAGATTTCGTGAGAAGAAGAGACCTCAAGAAAGGGGATGAGATCGGATTTCATTGGGATCCATATAATTGCGTTTTCAATTTCTGTGTCCTTAAACGAGCTATGCCAGAGAATTAA

[0464] SEQ ID NO:16 (Amino acid sequence of E1LB-D7; Lof):

[0465] MSLQSQIPSKFKIIFISSNMSNHSDEKEQCQKKRKSTICEASNFRTSRRTATKMKRR

[0466] SEQ ID NO:17 (CDS sequence of E1LB-D139; Lof):

[0467] ATGAGTTTACAATCTGCAGCAACAAAAATGAAGAGGAGATGAACAAGGGAGTTTCAACAACACTGAAGCTTTATGATGACCCTTGGAAGATCAAGAAGACGCTAACCGATAGCGATTTGGGAATCCTAAGTAGACTCTCGCTGGCTACAGATTTGGTGAAGAAGCAAATTTTGCCTATGTTGGGTGCAGATCATGCAAGAGCTGCAGAAACTGAAGAAGGGACCCCAGTTAGAGTTTGGGACATGGACACCAAATCCATGCACCAGCTCGTTCTAAAGCGATGGTCTTCTTCCAAGAGCTATGTTCTTATTGCAAAGTGGAACCAAGATTTCGTGAGAAGAAGAGACCTCAAGAAAGGGGATGAGATCGGATTTCATTGGGATCCATATAATTGCGTTTTCAATTTCTGTGTCCTTAAACGAGCTATGCCAGAGAATTAA

[0468] SEQ ID NO:18 (Amino acid sequence of E1LB-D139; Lof):

[0469] MSLQSAATKMKRR

[0470] SEQ ID NO:19 (CDS sequence of E1LB-D3; Lof):

[0471] ATGAGTTTACAATCACAAATCCCATCAAAGTTTAAAATAATATTCATCTCTTCCAACATGAGCAATCATTCAGATGAGAAGGAGCAGTGTCAAAAGAAGAGGAAATCCACCATATGTGAAGCCTCCAACTTTAGGACATCAAGGAGAATCTGCAGCAACAAAAATGAAGAGGAGATGAACAAGGGAGTTTCAACAACACTGAAGCTTTATGATGACCCTTGGAAGATCAAGAAGACGCTAACCGATAGCGATTTGGGAATCCTAAGTAGACTCTCGCTGGCTACAGATTTGGTGAAGAAGCAAATTTTGCCTATGTTGGGTGCAGATCATGCAAGAGCTGCAGAAACTGAAGAAGGGACCCCAGTTAGAGTTTGGGACATGGACACCAAATCCATGCACCAGCTCGTTCTAAAGCGATGGTCTTCTTCCAAGAGCTATGTTCTTATTGCAAAGTGGAACCAAGATTTCGTGAGAAGAAGAGACCTCAAGAAAGGGGATGAGATCGGATTTCATTGGGATCCATATAATTGCGTTTTCAATTTCTGTGTCCTTAAACGAGCTATGCCAGAGAATTAA

[0472] SEQ ID NO:20 (Amino acid sequence of E1LB-D3; Lof):

[0473] MSLQSQIPSKFKIIFISSNMSNHSDEKEQCQKKRKSTICEASNFRTSRRICSNKNEEEMNKGVSTTLKLYDDPWKIKKTLTDSDLGILSRLSLATDLVKKQILPMLGADHARAAETEEGTPVRVWDMDTKSMHQLVLKRWSSSKSYVLIAKWNQDFVRRRDLKKGDEIGFHWDPYNCVFNFCVLKRAMPEN

[0474] SEQ ID NO:21 (CDS sequence of E1LB-D6; Lof):

[0475] ATGAGTTTACAATCACAAATCCCATCAAAGTTTAAAATAATATTCATCTCTTCCAACATGAGCAATCATTCAGATGAGAAGGAGCAGTGTCAAAAGAAGAGGAAATCCACCATATGTGAAGCCTCCAACTTTAGGACATCAAGGAGAAGCAGCAACAAAAATGAAGAGGAGATGAACAAGGGAGTTTCAACAACACTGAAGCTTTATGATGACCCTTGGAAGATCAAGAAGACGCTAACCGATAGCGATTTGGGAATCCTAAGTAGACTCTCGCTGGCTACAGATTTGGTGAAGAAGCAAATTTTGCCTATGTTGGGTGCAGATCATGCAAGAGCTGCAGAAACTGAAGAAGGGACCCCAGTTAGAGTTTGGGACATGGACACCAAATCCATGCACCAGCTCGTTCTAAAGCGATGGTCTTCTTCCAAGAGCTATGTTCTTATTGCAAAGTGGAACCAAGATTTCGTGAGAAGAAGAGACCTCAAGAAAGGGGATGAGATCGGATTTCATTGGGATCCATATAATTGCGTTTTCAATTTCTGTGTCCTTAAACGAGCTATGCCAGAGAATTAA

[0476] SEQ ID NO:22 (Amino acid sequence of E1LB-D6; Lof):

[0477] MSLQSQIPSKFKIIFISSNMSNHSDEKEQCQKKRKSTICEASNFRTSRRSSNKNEEEMNKGVSTTLKLYDDPWKIKKTLTDSDLGILSRLSLATDLVKKQILPMLGADHARAAETEEGTPVRVWDMDTKSMHQLVLKRWSSSKSYVLIAKWNQDFVRRRDLKKGDEIGFHWDPYNCVFNFCVLKRAMPEN

[0478] SEQ ID NO:23 (CDS sequence of E1LB-D9; Lof):

[0479] ATGAGTTTACAATCACAAATCCCATCAAAGTTTAAAATAATATTCATCTCTTCCAACATGAGCAATCATTCAGATGAGAAGGAGCAGTGTCAAAAGAAGAGGAAATCCACCATATGTGAAGCCTCCAACTTTAGGACATCAAGGAGAAGCAACAAAAATGAAGAGGAGATGAACAAGGGAGTTTCAACAACACTGAAGCTTTATGATGACCCTTGGAAGATCAAGAAGACGCTAACCGATAGCGATTTGGGAATCCTAAGTAGACTCTCGCTGGCTACAGATTTGGTGAAGAAGCAAATTTTGCCTATGTTGGGTGCAGATCATGCAAGAGCTGCAGAAACTGAAGAAGGGACCCCAGTTAGAGTTTGGGACATGGACACCAAATCCATGCACCAGCTCGTTCTAAAGCGATGGTCTTCTTCCAAGAGCTATGTTCTTATTGCAAAGTGGAACCAAGATTTCGTGAGAAGAAGAGACCTCAAGAAAGGGGATGAGATCGGATTTCATTGGGATCCATATAATTGCGTTTTCAATTTCTGTGTCCTTAAACGAGCTATGCCAGAGAATTAA

[0480] SEQ ID NO:24 (Amino acid sequence of E1LB-D9; Lof):

[0481] MSLQSQIPSKFKIIFISSNMSNHSDEKEQCQKKRKSTICEASNFRTSRRSNKNEEEMNKGVSTTLKLYDDPWKIKKTLTDSDLGILSRLSLATDLVKKQILPMLGADHARAAETEEGTPVRVWDMDTKSMHQLVLKRWSSSKSYVLIAKWNQDFVRRRDLKKGDEIGFHWDPYNCVFNFCVLKRAMPEN

[0482] SEQ ID NO:25 (Forward primer of E1Lb):

[0483] GTTATCATGCTTGAAAATGATGATG

[0484] SEQ ID NO:26 (Reverse primer of E1Lb):

[0485] GTGCATAGATCTCATGCTAGACCT

[0486] SEQ ID NO:27 (forward primer of E1):

[0487] TCCATTGTTTGTAGCGCATGGTC

[0488] SEQ ID NO:28 (reverse primer of E1):

[0489] CATAGATCTCCTGCTAGCTAGACC

[0490] SEQ ID NO:29 (sequencing primer of E1):

[0491] GCTAGTAGTGTAAACACTCAAAACAC

[0492] SEQ ID NO:30 (sequencing primer of E1Lb):

[0493] TGCCTTTCTACTGGCTATGAC

[0494] SEQ ID NO:31 (forward primer of Cas12a):

[0495] GGGCAAGCTCTACATGTTCCAG

[0496] SEQ ID NO:32 (reverse primer of Cas12a):

[0497] CCGTGGTTGTTCTCGTCGA

[0498] SEQ ID NO:33 (forward primer for Adh):

[0499] AGGTGTGGATCGGGCTGTT

[0500] SEQ ID NO:34 (reverse primer for Adh):

[0501] CATCGTGGACGCATTCGA

[0502] SEQ ID NO:35 (probe for Cas12a):

[0503] CGTGGCTCTTGTCGGAGAAGTCCTTGTT

[0504] SEQ ID NO:36 (probe for Adh):

[0505] ACTGGCAGCATCCAAGCCATGGTCT

[0506] SEQ ID NO: 37 (second NLS basic domain for targeting E1 and E1Lb loci)

[0507] gRNA) (PAM: TTTA):

[0508] TTTAGGACATCAAGGAGAAGATTCTGC< / nobr>

Claims

1. A method for establishing where a soybean plant or its seeds should grow, the method comprising: include: a. introducing mutations at the E1 locus and / or E1LB locus of the soybean plant genome via genome modification using site-directed nucleases; b. selfing the plant for one or more generations to produce offspring plants homozygous for mutations at the E1 locus and / or the E1LB locus; c. obtaining DNA from said offspring plants; d. determining the allelic combination of the progeny plant via an assay indicating a mutation introduced at the E1 locus and / or the E1LB locus; and e. assigning changes in flowering time and / or maturity time to the progeny plants based on the determined allele combination, wherein the changes in flowering time and / or maturity time are relative to control plants that do not contain the determined allele combination.

2. The method of claim 1, wherein the mutation is introduced at the nuclear localization signal (NLS) of the E1 locus and / or the E1LB locus.

3. The method of claim 2, wherein the mutation is introduced at the basic domain of the NLS of the E1 locus and / or the E1LB locus.

4. The method of claim 2 or 3, wherein the mutation is introduced at the second basic domain of the two basic domains of the nuclear localization signal (NLS) of the E1 locus and / or the E1LB locus, wherein the second basic domain is downstream relative to the first basic domain of the NLS.

5. The method of any one of claims 1 to 4, wherein the introducing comprises transforming a plant cell with an expression cassette comprising: (i) a nucleic acid encoding the site-directed nuclease; and (ii) a nucleic acid encoding at least one guide RNA (gRNA) directed against a target sequence at the E1 locus and / or the E1LB locus.

6. The method of claim 5, wherein the at least one gRNA is directed against a target sequence comprising the second basic domain of the nuclear localization signal (NLS) at one of the E1 locus and the E1LB locus.

7. The method of claim 5, wherein the at least one gRNA is directed against a target sequence comprising the second basic domain of the nuclear localization signal (NLS) at each of the E1 locus and the E1LB locus.

8. The method of any one of claims 5 to 7, wherein the nucleic acid encoding the site-directed nuclease is operably linked to a first promoter of the expression cassette, and wherein the nucleic acid encoding the at least one gRNA is operably linked to a second promoter of the expression cassette.

9. The method of claim 8, wherein the expression cassette further comprises an enhancer operably linked to the first promoter or the second promoter.

10. The method of any one of claims 1-9, wherein the site-directed nuclease is selected from the group consisting of: mega nuclease (MN), zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), Cas9 nuclease, Cfp1 nuclease, dCas9-Fok1, dCpf1-Fok1, chimeric Cas9-cytidine deaminase, chimeric Cas9-adenine deaminase, chimeric FEN1-Fok1, and Mega-TAL, nickase Cas9 (nCas9), chimeric dCas9 non-Fok1 nuclease, and dCpf1 non-Fok1 nuclease.

11. The method of claim 1, wherein the mutation introduced into the E1 locus and / or the E1LB locus is selected from the group consisting of: allele substitution, one or more base insertions, one or more base deletions.

12. The method of claim 1, wherein the allele combination comprises one or more of the following: a) Mutant E1 alleles that cause loss of E1 protein function; b) a mutant E1 allele resulting in a partial function of the E1 protein; c) a mutant E1LB allele resulting in loss of function of the E1LB protein; and d) a mutant E1LB allele resulting in a partial functionality of the E1LB protein.

13. The method of claim 1, wherein the mutant allele at the E1LB locus corresponds to any one of SEQ ID NOs: 15, 17, 19, 21 and 23; or encodes a mutant E1LB protein corresponding to any one of SEQ ID NOs: 16, 18, 20, 22 and 24; and wherein the mutant allele at the E1 locus corresponds to any one of SEQ ID NOs: 5, 7, 9, 11 and 13; or encodes a mutant E1 protein corresponding to any one of SEQ ID NOs: 6, 8, 10, 12 and 14.

14. The method of any one of claims 1-13, wherein the progeny plant has a modified flowering time and / or maturity time relative to the control plant, and wherein the control plant comprises a wild-type allele at each of the E1 locus and the E1LB locus.

15. The method of any one of claims 1-14, wherein specifying a change in flowering time and / or maturity time comprises specifying a shortened number of days in flowering time and / or maturity time of the progeny plant relative to the control plant.

16. The method of any one of claims 1-16, wherein the change in the designated flowering time comprises a decrease in the number of days between stage VE and stage R1 of the progeny plant relative to the control plant, and / or wherein the change in the designated maturity time comprises a decrease in the number of days between stage R1 and stage R7 or R8 of the progeny plant relative to the control plant.

17. The method of claim 5, wherein the introducing further include: regenerating a transformed TO plant from the transformed plant cell, the transformed TO plant having a plurality of T1 seeds, wherein the plurality of T1 seeds contain a plurality of unique edits in the E1 locus and / or the E1LB locus; growing a plurality of T1 plants from the T1 seeds; as well as The T1 plants are selfed for one or more generations to obtain progeny plants that are homozygous for the introduced mutation at the E1 locus and / or the E1LB locus.

18. The method of claim 17, wherein the allele combination is determined include: Sequencing the E1 locus and the E1LB locus of the progeny plant; Sequencing the E1 locus and the E1LB locus of the T0 plant; as well as The sequences of the E1 locus and the E1LB locus of the progeny plant are aligned with the corresponding sequences of the progeny plant to determine the mutation introduced into the E1 locus and / or the E1LB locus.

19. A method for producing a soybean plant with modified flowering time, the method include: introducing edits into one or more of the E1 gene and the E1LB gene of a soybean plant cell to generate a mutant E1 allele and / or a mutant E1LB allele having reduced function relative to a corresponding wild-type allele; regenerating an edited plant from the edited plant cell; as well as The edited plant is selfed to obtain an edited offspring plant comprising a non-naturally occurring allele combination, wherein the non-naturally occurring allele combination comprises one or more of the mutant E1 allele and the mutant E1LB allele, wherein the edited offspring plant has a modified flowering time and / or maturity time relative to the flowering time and / or maturity time of a control plant comprising the wild-type E1 allele and the wild-type E1LB allele.

20. The method of claim 19, wherein introducing the edit into the E1 gene comprises introducing a plurality of base pair deletions into the E1 gene, wherein the mutant E1 allele corresponds to any one of SEQ ID NOs: 5, 7, 9, 11, and 13, and encodes an in-frame deletion mutant E1 protein or a truncated E1 protein corresponding to any one of SEQ ID NOs: 6, 8, 10, 12, and 14; and wherein introducing the edit into the E1LB gene comprises introducing a plurality of base pair deletions into the E1LB gene, wherein the mutant E1LB allele corresponds to any one of SEQ ID NOs: 15, 17, 19, 21, and 23, and encodes an in-frame deletion mutant E1 protein or a truncated E1 protein corresponding to any one of SEQ ID NOs: 15, 17, 19, 21, and 23. An in-frame deletion mutant E1LB protein or a truncated E1LB protein of any one of NO:16, 18, 20, 22 and 24, wherein the truncated E1 protein has no functional activity relative to the wild-type E1 protein, wherein the in-frame deletion mutant E1 protein has partial functional activity relative to the wild-type E1 protein, wherein the truncated E1LB protein has no functional activity relative to the wild-type E1LB protein, and wherein the in-frame deletion mutant E1LB protein has partial functional activity relative to the wild-type E1LB protein.

21. The method of claim 19 or 20, wherein introducing the edit into the E1 gene comprises introducing the edit into the second basic domain of a nuclear localization signal (NLS) of the E1 gene; and wherein introducing the edit into the E1LB gene comprises introducing the edit into the second basic domain of a nuclear localization signal (NLS) of the E1LB gene.

22. The method of any one of claims 19-21, wherein the editing is introduced into the E1 gene and / or the E1LB gene include: The plant cell is transformed with an expression cassette comprising: (i) a nucleic acid encoding a site-directed nuclease operably linked to a promoter, wherein the promoter is optionally further linked to an enhancer configured to enhance transcription of the site-directed nuclease by the promoter; and (ii) a nucleic acid encoding at least one guide RNA (gRNA) directed against a target sequence in the second basic domain of the NLS of the E1 gene and / or the E1LB gene.

23. The method of claim 19, wherein the flowering time of the edited progeny plant is shorter than the flowering time of the control plant.

24. The method of claim 19, wherein the relative maturity group value of the edited progeny plant is different from the relative maturity group value of the control plant.

25. An edited progeny plant according to any one of claims 19-24.

26. An additional progeny plant of the edited progeny plant of claim 25, wherein the additional progeny plant is obtained by breeding or selfing.

27. A non-naturally occurring soybean plant with modified flowering time, the non-naturally occurring soybean plant comprising a combination of alleles selected from the group consisting of: (a) a mutant E1LB allele resulting in partial expression of the E1LB protein and a wild-type E1 allele; (b) mutant E1LB allele resulting in loss of E1LB protein expression and wild-type E1 allele; (c) a mutant E1LB allele resulting in partial expression of the E1LB protein and a mutant E1 allele resulting in partial expression of the E1 protein; (d) mutant E1LB alleles resulting in loss of expression of the E1LB protein and mutant E1 alleles resulting in partial expression of the E1 protein; (e) mutant E1LB alleles resulting in partial expression of E1LB protein and mutant E1 alleles resulting in loss of E1 protein expression; (f) a mutant E1LB allele resulting in loss of E1LB protein expression and a mutant E1 allele resulting in loss of E1 protein expression; (g) a mutant E1 allele resulting in partial expression of the E1 protein and a wild-type E1LB allele; as well as (h) a mutant E1 allele that results in loss of expression of the E1 protein and a wild-type E1LB allele; wherein the flowering time of the non-naturally occurring soybean plant is modified relative to a control plant comprising the wild-type E1 allele and the wild-type E1LB allele.

28. The soybean plant of claim 27, wherein the mutant E1LB allele corresponds to any one of SEQ ID NOs: 15, 17, 19, 21, and 23; or encodes a mutant E1LB protein corresponding to any one of SEQ ID NOs: 16, 18, 20, 22, and 24; and wherein the mutant E1 allele corresponds to any one of SEQ ID NOs: 5, 7, 9, 11, and 13; or encodes a mutant E1 protein corresponding to any one of SEQ ID NOs: 6, 8, 10, 12, and 14.

29. The soybean plant of claim 27 or 28, wherein the mutant E1LB allele resulting in partial expression or the mutant E1LB allele resulting in loss of expression is introduced by editing the E1LB gene of the plant using a DNA modifying enzyme.

30. The soybean plant of claim 27 or 28, wherein the mutant El allele resulting in partial expression or the mutant El allele resulting in loss of expression is introduced by editing the El gene of the plant using a DNA modification enzyme.

31. A breeding method, the breeding method include: Crossing the non-naturally occurring soybean plant of claim 27 with a different soybean plant that does not contain the allele combination of the non-naturally occurring soybean plant; as well as Progeny plants are selected having such modified flowering.

32. A modified soybean plant or plant part thereof, comprising a non-naturally occurring mutant allele at the E1 locus and / or the E1Lb locus, wherein the non-naturally occurring mutant allele is introduced via genome modification using a site-directed nuclease.

33. The modified soybean plant or plant part thereof of claim 32, wherein the non-naturally occurring mutant allele is a homozygous mutant allele.

34. The modified soybean plant or plant part thereof of claim 32, comprising a non-naturally occurring mutant allele at each of the E1 locus and the E1Lb locus, wherein both the E1 locus and the E1Lb locus comprise homozygous mutant alleles.

35. The modified soybean plant or plant part thereof of any one of claims 32-34, wherein the mutant allele exhibits a decrease in expression or enzyme activity relative to an unmodified wild-type E1 or E1LB gene allele.

36. The modified soybean plant or plant part thereof of any one of claims 32-35, wherein the mutant allele at the E1 locus or the E1LB locus comprises a mutation in the second basic domain of the nuclear localization signal (NLS) of the protein encoded by the gene.

37. The modified soybean plant or plant part thereof of any one of claims 32-36, wherein the mutant allele at the E1 locus and / or the E1LB locus comprises one or more mutation types selected from the group consisting of a nonsense mutation, an in-frame deletion mutation, a missense mutation, a frameshift mutation, a splice site mutation, and any combination thereof.

38. The modified soybean plant or plant part thereof of any one of claims 32-37, wherein the mutant allele at the E1 locus results in one of: E1 protein truncation, non-functional E1 protein, E1 protein with reduced function, a premature stop codon in the E1 gene, and an in-frame deletion in the E1 gene; and wherein the mutant allele at the E1LB locus results in one of: E1LB protein truncation, non-functional E1LB protein, E1LB protein with reduced function, a premature stop codon in the E1LB gene, and an in-frame deletion in the E1LB gene.

39. The modified soybean plant or plant part thereof of any one of claims 32-38, wherein the modified plant has a shorter flowering time than a control plant comprising an unmodified wild-type E1 and / or wild-type E1LB gene allele.

40. The modified soybean plant or plant part thereof of claim 39, wherein the reduced time to flowering comprises fewer days between stage VE and stage R1 of the modified plant relative to the control plant.

41. The modified soybean plant or plant part thereof of any one of claims 32-38, wherein the modified plant has a time to maturity that is less than a control plant comprising an unmodified wild-type E1 and / or wild-type E1LB gene allele.

42. The modified soybean plant or plant part thereof of claim 41, wherein the reduced time to maturity comprises fewer days between the R1 stage and the R7 stage of the modified plant relative to the control plant.

43. The modified soybean plant or plant part thereof of any one of claims 32-42, wherein the homozygous mutant allele comprises a homozygous mutation at the E1 locus selected from the group consisting of: (a) an 8 bp deletion from position 147 to 154 of the E1 gene; (b) a 13 bp deletion from position 144 to 156 of the E1 gene; (c) a 25 bp deletion from position 131 to 155 of the E1 gene; (d) a 9 bp deletion from position 146 to 154 of the E1 gene; and (e) a 15 bp substitution from position 145 to 159 of the E1 gene, The position refers to the E1 gene of SEQ ID NO:

1.

44. The modified soybean plant or plant part thereof of claim 43, wherein the homozygous mutation at the E1 locus corresponds to any one of SEQ ID NOs: 5, 7, 9, 11, and 13; or encodes a mutant E1 protein corresponding to any one of SEQ ID NOs: 6, 8, 10, 12, and 14.

45. The modified soybean plant or plant part thereof of any one of claims 32-42, wherein the homozygous mutant allele comprises a homozygous mutation at the E1LB locus selected from the group consisting of: (a) a 7 bp deletion from position 149 to 155 of the E1LB gene; (b) a 3 bp deletion from position 149 to 151 of the E1LB gene; (c) a 139 bp deletion from position 13 to 151 of the E1LB gene; (d) a 6 bp deletion from position 149 to 154 of the E1LB gene; and (e) a 9 bp deletion from position 148 to 156 of the E1LB gene, The position refers to the E1LB gene of SEQ ID NO:

3.

46. ​​The modified soybean plant or plant part thereof of claim 45, wherein the homozygous mutation at the E1LB locus corresponds to any one of SEQ ID NOs: 15, 17, 19, 21, and 23; or encodes a mutant E1LB protein corresponding to any one of SEQ ID NOs: 16, 18, 20, 22, and 24.